Distinct interactions of eIF4A and eIF4E with RNA helicase Ded1 stimulate translation in vivo
Yeast DEAD-box helicase Ded1 stimulates translation initiation, particularly of mRNAs with structured 5'UTRs. Interactions of the Ded1 N-terminal domain (NTD) with eIF4A, and Ded1-CTD with eIF4G, subunits of eIF4F, enhance Ded1 unwinding activity and stimulation of preinitiation complex (PIC) assembly in vitro. However, the importance of these interactions, and of Ded1-eIF4E association, in vivo were poorly understood. We identified separate amino acid clusters in the Ded1-NTD required for binding to eIF4A or eIF4E in vitro. Disrupting each cluster selectively impairs native Ded1 association with eIF4A or eIF4E, and reduces cell growth, polysome assembly, and translation of reporter mRNAs with structured 5'UTRs. It also impairs Ded1 stimulation of PIC assembly on a structured mRNA in vitro. Ablating Ded1 interactions with eIF4A/eIF4E unveiled a requirement for the Ded1-CTD for robust initiation. Thus, Ded1 function in vivo is stimulated by independent interactions of its NTD with eIF4E and eIF4A, and its CTD with eIF4G.
Eukaryotic translation initiation is an intricate process that ensures accurate selection and decoding of the mRNA start codon. Initiation generally occurs through the scanning mechanism, which can be divided into the following discrete steps: (1a) 43S preinitiation complex (PIC) formation on the small (40S) ribosomal subunit by recruitment of methionyl initiator tRNA Met-tRNAiMet in a ternary complex (TC) with GTP-bound eukaryotic initiation factor 2 (eIF2), facilitated by 40S-bound eIFs −1, −1A, −3, and −5; (1b) mRNA activation by binding of the eIF4F complex to the 7-methylguanosine capped 5’ end; (2) 43S PIC attachment to the mRNA 5’ end; (3) Scanning of the mRNA 5’ untranslated region (UTR) by the PIC for a start codon in good sequence context; (4a) Start codon selection by Met-tRNAiMet to form the 48S PIC; (4b) irreversible hydrolysis of GTP in the ternary complex, accompanied by release of eIF1 and its replacement on the 40S subunit by the eIF5 N-terminal domain; and (4 c) release of eIF2-GDP and eIF5 and recruitment of 60S subunit joining factor eIF5B by eIF1A; (5) Dissociation of eIF1A and eIF5B and joining of the 60S subunit to form the 80S initiation complex (Jackson et al., 2010; Hinnebusch, 2014).
The eIF4F complex, which stimulates 43S PIC recruitment to mRNA, comprises eIF4E, eIF4A, and eIF4G. The eIF4E (encoded by the CDC33 gene in yeast) is a 24 kDa protein that binds directly to the 5’ cap of the mRNA. eIF4A (encoded by TIF1 and TIF2 genes in yeast) is a 44 kDa DEAD-box RNA helicase thought to resolve mRNA structures that impede PIC attachment or scanning. eIF4G1 (encoded by TIF4631 in yeast) is a 107 kDa scaffold protein harboring binding sites for RNA (named RNA1, RNA2, RNA3), the two other eIF4F components (eIF4E and eIF4A), and the poly(A) binding protein (PABP), hence promoting formation of a circular ‘closed-loop’ messenger ribonucleoprotein (mRNP). eIF4G can also interact with eIF3 (in mammals) or eIF5 (in yeast) to facilitate 43S PIC recruitment to the mRNA. eIF4G1 has a paralog, eIF4G2 (encoded by TIF4632 in yeast), which can make similar contacts with RNA and initiation factors and thereby promote initiation (Clarkson et al., 2010). The functions of these canonical eIF4F components have been studied in considerable detail (Jackson et al., 2010; Hinnebusch, 2014).
Recently, other DEAD-box RNA helicases besides eIF4A have been implicated in PIC attachment and scanning, including yeast Ded1 (homologous to Ddx3 in humans). Ded1 is an essential protein that stimulates bulk translation in vivo (Chuang et al., 1997; de la Cruz et al., 1997), and is especially important for translation of a large subset of yeast mRNAs characterized by long, structured 5’ UTRs. Many such Ded1-hyperdependent mRNAs, identified by 80S ribosome footprint profiling of ded1 mutants (Sen et al., 2015), were shown recently to require Ded1 in vivo for efficient 43S PIC attachment or subsequent scanning of the 5’UTR using the technique of 40S subunit profiling (Sen et al., 2019). Employing a fully reconstituted yeast translation initiation system, we further showed that Ded1 stimulates the rate of 48S PIC assembly on all mRNAs tested, but confers greater stimulation of Ded1-hyperdependent versus Ded1-hypodependent mRNAs (as defined by 80S ribosome profiling) in a manner dictated by stable stem-loop secondary structures in the 5’UTRs of the hyperdependent group (Gupta et al., 2018). Ded1 cooperates with its paralog Dbp1 in stimulating translation of a large group of mRNAs in vivo, and Dbp1 functions similarly to Ded1 in stimulating 48S PIC assembly in the yeast reconstituted system (Sen et al., 2019).
In addition to its canonical DEAD box helicase region comprised of two RecA-like domains, Ded1 contains additional N-terminal and C-terminal domains (NTD, CTD) (Figure 1A) that are not well conserved in amino acid sequence even within the subfamily comprised of Ded1 and mammalian Ddx3 helicases; and are thought to be largely unstructured (Sharma and Jankowsky, 2014). Distinct N-terminal and C-terminal extensions found immediately flanking the helicase core (NTE, CTE in Figure 1A) are relatively more conserved in the Ded1/Ddx3 subfamily, and at least for Ddx3, have partially defined structures and enhance the unwinding activity of the helicase core in vitro (Floor et al., 2016). Ded1 can interact in vitro with all three subunits of eIF4G, binding to the C-terminal RNA3 domain of eIF4G via the CTD, and interacting with eIF4A via the NTD (Hilliker et al., 2011; Senissar et al., 2014; Gao et al., 2016). Interaction of eIF4A with the Ded1-NTD stimulates the ability of purified Ded1 to unwind model RNA duplexes, whereas Ded1 interaction with eIF4G decreases the rate of RNA unwinding while increasing Ded1 affinity for RNA in vitro (Gao et al., 2016). Recently, we showed that the ability of Ded1 to stimulate 48S PIC formation in the reconstituted yeast system is impaired by elimination of either the Ded1-NTD, the Ded1-CTD, or the RNA2 or RNA3 domains of eIF4G1, with correlated defects for several mRNAs on removing the Ded1-CTD or eIF4G1 RNA3 domains that mediate Ded1/eIF4G1 interaction. These findings provided functional evidence that Ded1 association with the eIF4F subunits eIF4G and either eIF4A or eIF4E enhances Ded1 stimulation of 48S PIC assembly on native mRNAs (Gupta et al., 2018). It has been proposed that the majority of Ded1 exists in a stoichiometric complex with eIF4F in yeast cells (Gao et al., 2016).
There is evidence that the Ded1-CTD/eIF4G interaction promotes Ded1 stimulation of translation in cell extracts, and also the ability of Ded1, when highly overexpressed in cells, to repress translation and promote formation of P-bodies—cytoplasmic granules that function in storage or decay of translationally silenced mRNA. However, the in vivo importance of the Ded1 CTD in stimulating translation at native levels of Ded1 expression is unclear, as its elimination does not affect cell growth on nutrient-replete medium at low temperatures where ded1 mutations generally have the strongest phenotypes (Hilliker et al., 2011). Instead, recent results indicate a role for the Ded1 CTD in down-regulating translation under conditions of reduced activity of the TORC1 protein kinase, which might entail increased degradation of eIF4G (Aryanpur et al., 2019). In contrast, the N-terminal region of Ded1 is clearly important for WT cell growth (Hilliker et al., 2011; Floor et al., 2016; Gao et al., 2016). There is also limited evidence that eIF4A binding to this region is functionally important in vivo, based on the finding that eIF4A overexpression can mitigate the growth phenotypes of a ded1 allele with mutations in multiple domains, but not one only lacking the N-terminal 116 residues that encompass the eIF4A interaction site (Gao et al., 2016). However, this ΔNTD1-116 truncation might remove other functional determinants besides the eIF4A binding site that cannot be rescued by eIF4A overexpression, including a portion of the conserved NTE that enhances unwinding in vitro (Floor et al., 2016). Although Ded1 contains an 8-amino acid segment with similarity to a sequence in mammalian Ddx3 shown to bind eIF4E (Shih et al., 2008), and mutations in this Ded1 segment confer slow-growth phenotypes in yeast (Hilliker et al., 2011; Senissar et al., 2014), it was not shown that eIF4E binds to the Ded1 NTD nor requires the conserved motif for this interaction. As the binding determinants for eIF4E in Ded1 have not been identified, it is also unclear whether eIF4E interaction with Ded1 is physiologically important.
In this study, we set out to pinpoint the binding sites for eIF4A and eIF4E in the Ded1 NTD, which were not currently known, and to establish the importance of each individual interaction in promoting Ded1’s ability to stimulate translation of Ded1-hyperdependent mRNAs in vivo. We have mutationally dissected Ded1 N-terminal residues extending up to the conserved NTE and identified specific amino acids whose substitution impaired Ded1 binding to recombinant eIF4A or eIF4E in vitro, which delineated non-overlapping NTD residues required for interaction with each factor. We could then demonstrate that NTD substitutions that selectively disrupt its association with eIF4A or eIF4E in vitro also impair association of Ded1 with native eIF4A or eIF4E in vivo, and diminish Ded1’s ability to promote cell growth, bulk translation initiation, and translation of Ded1-dependent reporter mRNAs harboring defined stem-loop (SL) structures in their 5’UTRs, in yeast cells. We further showed that selectively disrupting Ded1 interactions with eIF4E or eIF4A by these NTD substitutions impaired Ded1 acceleration of 48S PIC assembly on a SL-containing reporter mRNA in the yeast reconstituted system. We provided additional genetic evidence that the key Ded1 NTD residues promote translation in vivo specifically by mediating interaction with eIF4A or eIF4E, and that this constitutes the critical in vivo function of the entire Ded1 NTD. Finally, we found that the Ded1 CTD becomes crucial for robust cell growth and translation initiation in vivo when Ded1’s contacts with eIF4A or eIF4E are absent and its association with eIF4F must rely on Ded1-CTD interactions with eIF4G. Together, our results establish that the individual interactions of Ded1 with eIF4A, eIF4E and eIF4G that stabilize the eIF4F·Ded1 complex all promote Ded1 function in stimulating translation initiation in nutrient-replete yeast cells.
Evidence that eIF4A and eIF4E both interact with the Ded1-NTD in vitro
Discrete binding determinants for eIF4A and eIF4E within the yeast Ded1 protein were unknown, which has made it difficult to assess the physiological importance of each interaction in vivo. To identify amino acids important for each interaction, we assayed binding of bacterially expressed glutathione-S-transferase (GST) fusions made to full-length yeast eIF4A1 or eIF4E to in vitro translated [35S]-labeled Ded1 polypeptides, beginning with full-length (FL) Ded1 (amino acids 1–604) and truncated Ded1 variants lacking NTD residues 2–92 (ΔN2-92), CTD residues 562–604 (ΔC562-604), or both domains (ΔNC) (Figure 1A). The labeled Ded1 polypeptides recovered with GST-eIF4A, GST-eIF4E, or GST alone on glutathione-agarose beads were resolved by SDS-PAGE, with the result that the FL Ded1 polypeptide bound to both GST-eIF4A and GST-eIF4E, but not GST alone (Figure 1B, lanes 9 and 13 vs. 5), confirming specific, separate interactions of Ded1 with both eIF4A and eIF4E. These and all subsequent pull-down assays included RNAase treatment to insure that the interactions were not bridged by RNA.
The amounts of bound Ded1 polypeptides were quantified and normalized to the input amounts for each reaction, and mean percentages of the input amounts that bound to GST-eIF4A or GST-eIF4E in replicate pull-down experiments were compared between FL Ded1 and the three truncated Ded1 variants. For GST-eIF4A, binding of the ΔC562-604 and FL Ded1 polypeptides were comparable, whereas drastically reduced amounts of the ΔN2-92 and ΔNC variants were bound (Figure 1C). These results support previous findings that eIF4A interacts specifically with the Ded1 NTD (Gao et al., 2016). Eliminating the NTD reduced Ded1 binding to GST-eIF4E as well, although binding was also reduced to a lesser extent by deleting the Ded1 CTD (Figure 1D). Importantly, however, comparing the results for ΔNC and ΔN2-92 revealed that the low-level binding conferred by ΔN2-92 was not significantly diminished by ΔC562-604, whereas ΔN2-92 exacerbated the moderate binding defect of ΔC562-604 (Figure 1D). These results suggest that the Ded1 NTD is considerably more important than the CTD for eIF4E binding, and provide the first evidence that eIF4E binds directly to the yeast Ded1 NTD.
Ded1 has also been reported to interact through its C-terminus with eIF4G (Gao et al., 2016; Hilliker et al., 2011; Senissar et al., 2014). We verified this interaction under the conditions of our binding assay by determining that the ΔC562-604 truncation was sufficient to abolish binding by [35S]-labeled Ded1 to a GST-eIF4G fusion expressed in bacteria (Figure 1—figure supplement 1, lanes 10 and 12). Thus, the Ded1 CTD is essential for binding to eIF4G but is either dispensable or relatively unimportant for interactions with eIF4A or eIF4E, respectively.
eIF4A and eIF4E binding determinants in the Ded1 NTD are distinct and non-overlapping
To identify specific Ded1 residues critical for binding eIF4A and eIF4E in vitro, we generated [35S]-labeled variants of the FL Ded1 polypeptide containing clustered alanine substitutions, or in one case a deletion, of ten blocks of conserved amino acids located throughout the NTD (Figure 2A). While the main consideration for sequence conservation was similarity among other Saccharomycetaceae species (Figure 2—figure supplement 1A), most of these clusters include residues also conserved in higher eukaryotes (Figure 2—figure supplement 1B). Using the same GST pull-down assay as above, we observed that substituting Ded1 NTD residues 21–27, 29–35 and 51–57 conferred the greatest reductions in binding to GST-eIF4A (Figure 2B, cols. 5, 6, 8, bars in green hues), whereas residues 59–65 and 83–89 appear to be most important for binding to GST-eIF4E (Figure 2C, cols. 9,11, orange hues). These findings suggested that the critical binding determinants for eIF4A and eIF4E are located in adjacent, non-overlapping segments of the Ded1 NTD, located within residues 21–57 for eIF4A and within residues 59–89 for eIF4E.
To determine whether the non-contiguous binding determinants within each of these two intervals make additive contributions to binding eIF4A or eIF4E, we examined additional variants harboring combined substitutions of two different clusters. Whereas combining the contiguous substitutions 21–27 and 29–35 produced no further reduction in binding to GST-eIF4A compared to the single substitutions (Figure 2B, cols. 13 vs. 5 and 6), an additive reduction in binding was observed on combining the non-contiguous substitutions 21–27 and 51–57 (Figure 2B, cols. 14 vs. 5 and eight and Figure 2—figure supplement 2, cols. 5 vs. 1 and 2), which was comparable in its effect to deleting the entire (ΔNTD2-92) on binding to GST-eIF4A (Figure 2B, cols. 2 and 14, dark green hues). In contrast, combining the non-contiguous substitutions that individually impaired eIF4E binding produced reductions in binding by the 59-65/83-89 variant indistinguishable from those generated by the single substitutions (Figure 2C, cols. 16 vs. 9 and 11 and Figure 2—figure supplement 2, cols. 12 vs. 9 and 10). It is noteworthy that the two double substitutions that impair binding to GST-eIF4A (21-27/29-35 and 21-27/51-57) had little or no effect on binding to GST-eIF4E (Figure 2B–C, cols. 13–14), and that the double substitution 59-65/83-89 strongly reduced binding to GST-eIF4E with no significant effect on binding to GST-eIF4A (Figure 2B–C, col. 16). These last findings support the notion that the binding determinants for eIF4A and eIF4E are segregated into non-overlapping adjacent segments of the NTD.
Combining substitution 51–57 that selectively impairs binding to GST-eIF4A with the adjacent substitution 59–65 that selectively impairs binding to GST-eIF4E produced a binding defect to GST-eIF4E indistinguishable from that given by 59–65 alone (Figure 2C, cols. 15 vs. 8 and 9), supporting our conclusion that the binding determinants for eIF4E do not extend upstream into the region that binds eIF4A. However, the 59–65 substitution appeared to suppress the eIF4A binding defect of the adjacent upstream substitution 51–57 in the 51-57/59-65 variant (Figure 2B, cols. 15 vs. 8 and 9). One way to explain this ‘context dependence’ of the 51–57 substitution would be to propose that the residues in segment 59–65 that mediate eIF4E binding also antagonize binding of eIF4A to the contiguous segment 51–57 segment, such that their removal lessens the requirement for the eIF4A binding determinants in the 51–57 segment. Consistent with this possibility, we found that the 59–65 substitution did not suppress the stronger binding defect conferred by combining the non-contiguous substitution 21–27 with 51–57 in a 21-27/51-57/59-65 triple mutant (Figure 2—figure supplement 3, col. eight vs. col. 6). Regardless of the explanation, the 21-27/51-57 and 59-65/83-89 double substitutions provide Ded1 variants that selectively impair binding to eIF4A or eIF4E for our subsequent in vivo analysis.
The Ded1 NTD is highly unstructured (Floor et al., 2016) and harbors RGG/RG motifs (Rajyaguru and Parker, 2012). To examine whether these motifs contribute to Ded1 interactions with eIF4A or eIF4E, we examined substitutions R27A, G28A, and R51A within the presumptive eIF4A-binding region identified above. Interestingly, R27A impaired binding to GST-eIF4A to the same extent observed on substituting the entire cluster 21–27 in which R27 resides, whereas G28A and R51A had no effect (Figure 2—figure supplement 4B). This finding is in accordance with the fact that R27 is highly conserved in the family Saccharomycetaceae, as well as in animals (Figure 2—figure supplement 1A–B), whereas, G28 and R51 are not. In contrast, despite its strong sequence conservation, Ala substitution of R62 within the region implicated in eIF4E binding had no significant effect on binding to GST-eIF4E (Figure 2—figure supplement 4B, right graph); although we note that the adjacent residue at position 61 is also an Arg in S. cerevisiae.
We further reasoned that because the Ded1 NTD is intrinsically unstructured, its hydrophobic and/or aromatic residues may be solvent-exposed and available for protein-protein interactions. Accordingly, we examined substitutions of five Phe or Tyr residues located within the NTD blocks of residues implicated above in binding to eIF4A or eIF4E. Strikingly, substituting each of the aromatic residues Y65 and W88 reduced binding to GST-eIF4E to the same extent observed for Ala substitutions of the entire corresponding segments 59–65 and 83–89, respectively (Figure 2—figure supplement 4C). By contrast, the Y21A and F56A/F57A substitutions within the eIF4A binding determinants 21–27 and 51/57, respectively, had no significant effect on binding to GST-eIF4A (Figure 2—figure supplement 4C). Together, these last findings reinforce the identification of segments 59–65 and 83–89 as binding determinants for eIF4E, and further suggest that aromatic residues Y65 and W88 within these segments might mediate key hydrophobic interactions with eIF4E. Although Y65 is not highly conserved, W88 is invariant among the eukaryotic species we examined (Figure 2—figure supplement 1A–B).
Disruption of discrete binding determinants for eIF4A or eIF4E in the Ded1 NTD confers growth defects in vivo
Having identified substitutions in the Ded1 NTD that selectively reduce Ded1 binding to GST-eIF4A or GST-eIF4E in vitro, we addressed next whether these substitutions reduce Ded1 function in vivo. We began by asking whether the Ded1 NTD substitutions confer synthetic growth defects when combined with the temperature-sensitive (Ts-) ded1-952 mutation, which strongly impairs growth at 37°C (Sen et al., 2015) but confers only a moderate slow-growth (Slg-) phenotype at 34°C (Figure 3B, rows 1–2) when introduced as a plasmid-borne Myc13-tagged allele expressed from the native promoter (henceforth ded1-ts, Figure 3A) in a strain deleted for chromosomal DED1. Compared to ded1-ts alone, the ded1-ts alleles also containing the 21–27 or 51–57 mutations shown above to impair eIF4A binding in vitro conferred stronger Slg- phenotypes at 34°C, with a slightly greater defect when the two mutations were combined within ded1-ts-21-27/51-57 (Figure 3B, 34°C, rows 6–9). Similar findings were made for the 59–65, 83–89, and 59-65/83-89 mutations that selectively impair eIF4E binding to Ded1 in vitro (Figure 3B, row 6 vs. 10–12), except that the reductions in growth were less pronounced than observed for the 21–27 and 21-27/51-57 mutations that impair eIF4A binding (Figure 3B, cf. rows 10–12 vs. 7 and 9). In contrast, the 14–20 and Δ40–47 mutations that did not affect Ded1 binding to eIF4A or eIF4E in vitro also conferred no Slg- in combination with ded1-ts in vivo. (The apparent suppression of the ded1-ts phenotype by 14–20 was not reproduced in independent transformants.) Western analysis showed that neither the double substitution 21-27/51-57 nor the quadruple substitution 21-27/51-57,59-65/83-89 reduced the steady-state level of the ded1-ts product (Figure 3D, lanes 5–7), indicating that they impair Ded1 function and not its expression.
The single amino acid substitutions Y21A and R27A in the eIF4A binding region each conferred a Slg- phenotype at 34°C in combination with ded1-ts, which for R27A was greater than that observed for Y21A and comparable to that given by the 21–27 clustered substitution that encompasses both single-residue substitutions (Figure 3—figure supplement 1, rows 5–6 vs. 2–3). These phenotypes correlate with the stronger eIF4A binding defect given by R27A versus Y21A, and with the similar binding defects observed for R27A and the 21–27 variant in vitro (Figure 2—figure supplement 4B). Although Y21A had little effect on Ded1 binding to eIF4A in vitro (Figure 2—figure supplement 4B), the residue is highly conserved (Figure 2—figure supplement 1) and, hence, might have a greater impact in vivo. The F56A/F57A substitutions in the 51–57 interval, which had no effect on GST-eIF4A binding in vitro (Figure 2—figure supplement 4B) also had no effect on cell growth in combination with ded1-ts (Figure 3—figure supplement 1, rows 2 and 7). The Y65A and W88A single residue substitutions in the respective 59–65 and 83–89 segments of the eIF4E binding region each conferred moderate Slg- phenotypes in combination with ded1-ts indistinguishable from those given by the corresponding 59–65 and 83–89 clustered substitutions (Figure 3—figure supplement 1, rows 11–12 vs. 9–10). These last findings are in accordance with the defects in GST-eIF4E binding in vitro shown above for these single and clustered substitutions (Figure 2—figure supplement 4C). Taken together, the effects of single-residue and clustered NTD substitutions on Ded1 binding to GST-eIF4A or GST-eIF4E in vitro are generally well correlated with their effects on cell growth in combination with the ded1-ts allele, with relatively stronger growth defects associated with mutations that reduce Ded1 binding to eIF4A versus those conferring comparable reductions in Ded1 binding to eIF4E.
We also examined the effects of the NTD mutations on Ded1 function in the absence of the ded1-ts mutation, finding that the 21-27/51-57 double cluster mutation affecting eIF4A binding confers a cold-sensitive Slg- phenotype, which is exacerbated on combining it with the 59-65/83-89 double cluster mutations that impair eIF4E binding in vitro (Figure 3C, rows 1–4). Interestingly, the latter quadruple mutation conferred a strong Slg- phenotype comparable to that given by the ded1-Δ2–90 deletion allele lacking nearly the entire NTD, both in otherwise WT DED1 (Figure 3C, rows 4–5) and in the ded1-ts allele, which suggests that binding to eIF4A and eIF4E constitutes the key in vivo function of the Ded1 NTD. Again, Western analysis revealed that the double and quadruple substitutions, as well as the Δ2–90 NTD deletion, had little effect on Ded1 steady-state expression levels (Figure 3D, lanes 1–4).
Finally, we asked whether disrupting binding of the Ded1 NTD to eIF4A or eIF4E would reveal an impact on cell growth of eliminating the Ded1 CTD and its known interaction with eIF4G. Consistent with previous findings (Hilliker et al., 2011), the CTD deletion that removes the C-terminal 43 residues of Ded1 (ded1-ΔC) confers no growth defect when the rest of Ded1 is intact. Importantly, however, the ΔC mutation exacerbates the cold-sensitive Slg- phenotypes of all of the ded1 mutations examined containing single- or double cluster substitutions in the NTD that impair binding to either eIF4A or eIF4E. While the exacerbation by ΔC is subtle for the 51–57, 59–65, and 83–89 single-cluster mutations, it is pronounced for 21–27 and both double-cluster substitutions (Figure 4A, cf. adjacent rows). The exacerbation of the cold-sensitive growth phenotype of the NTD double-cluster mutations by ΔC occurred without reducing expression relative to the NTD variants with an intact CTD (Figure 4B, lanes 4–6). These findings are consistent with the idea that interaction of the Ded1 CTD with eIF4G is less critical for stabilizing the Ded1-eIF4E-eIF4A-eIF4G quaternary complex, activating Ded1 helicase function, or both, compared to the Ded1 NTD interactions with eIF4E and eIF4A; but that the importance of the CTD is increased when either the Ded1-eIF4E or Ded1-eIF4A interactions are impaired.
Evidence that discrete binding determinants in the Ded1 NTD are important for interactions with eIF4A and eIF4E in vivo
Having identified eIF4A and eIF4E binding determinants in the Ded1 NTD in vitro and also demonstrating their contributions to Ded1 function in supporting cell growth, we sought next to demonstrate the importance of these interaction sites for Ded1 association with eIF4A or eIF4E in vivo using immunoprecipitation of myc-tagged Ded1 from yeast lysates. To this end, the myc13-tagged ded1-ts alleles containing the 21-27/51-57 or 59-65/83-89 double-cluster mutations, ded1-ts containing no other mutations, or empty vector were introduced into a DED1 strain lacking the chromosomal genes encoding eIF4G1 and eIF4G2 and expressing HA-tagged eIF4G1 from a plasmid under the eIF4G2 promoter, and whole cell extracts (WCEs) were immunoprecipitated with anti-Myc antibodies. The eIF4A, eIF4E, and eIF4G1-HA all coimmunoprecipitated specifically with the myc13-tagged ded1-ts product, failing to be immunoprecipitated from the extract lacking a myc-tagged protein (Figure 5, rows 5–6), as expected for Ded1 interaction with eIF4F. The presence of mutations 21-27/51-57 in the ded1-ts allele, which impair Ded1 binding to GST-eIF4A in vitro (Figure 2B) reduced coimmunoprecipitation of the myc13-tagged product with native eIF4A, but not eIF4E or eIF4G1-HA from WCEs (Figure 5, rows 6–7). Moreover, mutations 59-65/83-89, which reduced Ded1 binding to GST-eIF4E in vitro (Figure 2C), specifically impaired coimmunoprecipition of eIF4E with the myc13-tagged ded1-ts/59-65/83-89 product (Figure 5, lanes 6 and 8). The results were unaffected by treating the immune complexes with RNAses A and T1 (Figure 5, lanes 9–12 vs. 5–8), suggesting that the interactions are not bridged by RNA. Thus, the binding determinants in the Ded1 NTD for eIF4A and eIF4E defined by in vitro pull-down assays with recombinant GST fusions to eIF4A or eIF4E are also crucial for association of native eIF4A or eIF4E with the ded1-ts product expressed at native levels in yeast cells. Because WT Ded1 is present in these cells, the reductions in eIF4E/eIF4A coimmunoprecipitation with the ded1-ts variants harboring NTD substitutions might have been intensified by competition with WT Ded1 for binding to eIF4F.
Our findings that the NTD substitutions selectively reduced association of the ded1-ts product with only eIF4E or eIF4A versus all three eIF4F subunits might indicate that Ded1 exists predominantly in binary complexes with each of the subunits of eIF4F; however, this would be odds with the expectation that the majority of Ded1 is associated with eIF4F in cells, based on estimates of the binding constant for Ded1 association with eIF4F and the cellular concentrations of these factors (Gao et al., 2016). Rather, it seems plausible that weakening the association of Ded1 with eIF4E leads to a specific reduction in eIF4E coimmunoprecipitation with ded1-ts owing to dissociation of eIF4E from the scaffold subunit eIF4G during the extensive washing steps involved in the experiment, notwithstanding the known stable interaction of eIF4E with eIF4G (Mitchell et al., 2010). The relatively lower affinity of yeast eIF4A for eIF4G (Mitchell et al., 2010; Park et al., 2012) makes this explanation even more likely for the selective loss of eIF4A association with mutated ded1-ts; although the existence of Ded1-eIF4A binary complexes in vivo has also been predicted (Gao et al., 2016).
Genetic evidence that eliminating interactions with eIF4A or eIF4E is responsible for growth defects conferred by substituting Ded1-NTD binding determinants
We sought next to provide evidence that eliminating the binding determinants for eIF4A or eIF4E in the Ded1 NTD confer growth defects owing to loss of the specific interaction with eIF4A or eIF4E, respectively. We reasoned that if a Ded1 NTD substitution confers a growth defect, but can still partially interact with its binding partner, then overexpression of the partner should reinstate the interaction by mass action and rescue normal cell growth. If however the Ded1 mutant cannot bind to the partner at all, then overexpressing the latter might have little effect on cell growth (Figure 6A). To test this prediction, we overexpressed eIF4A1 from a high-copy (hc) TIF1 plasmid in the panel of ded1-ts mutants with single or double cluster substitutions in the eIF4A binding region and measured growth rates by cell-spotting assays. eIF4A overexpression mitigated the Slg- phenotypes at 34°C of the 21–27, 29–35, and 51–57 single-cluster mutations, and also the 21-27/29-35 double cluster mutations (Figure 6B, rows 3–10, cf. adjacent rows), all of which conferred partial reductions in Ded1 binding to GST-eIF4A in vitro (Figure 2B), consistent with restored interaction of Ded1-eIF4A association by mass action. Importantly however, eIF4A overexpression did not mitigate the stronger Slg- phenotype conferred by the ded1-ts,21-27/51-57 double-cluster mutation (Figure 6B, rows 11–12), which reduced binding to GST-eIF4A to the low level conferred by the ΔN2-92 deletion that removes the entire eIF4A binding domain (Figure 2B). Nor did eIF4A overexpression mitigate the Slg- phenotype conferred by the 59-65/83-89 mutations that selectively impair binding to eIF4E (Figure 6—figure supplement 1), supporting the interpretation that suppression of the other NTD mutations that partially impair eIF4A binding results from restoration of Ded1-eIF4A association by mass action (Figure 6A). Western analysis verified that eIF4A was overexpressed similarly in all of the ded1 mutants (Figure 6C). These findings support the idea that Ded1 substitutions in the eIF4A-binding region of the NTD confer growth defects in vivo owing to impaired association with eIF4A in cells.
When we subjected the ded1-ts alleles containing single- or double cluster mutations in the eIF4E binding region to a similar analysis by overexpressing eIF4E from a hc CDC33 plasmid, we saw a uniform, modest exacerbation of growth defects for all strains (not shown), which may indicate that eIF4E overexpression is toxic for yeast. Instead, we exploited the fact that overexpressing WT DED1 can mitigate the growth defects conferred by the chromosomal eIF4E mutant allele cdc33-1 (de la Cruz et al., 1997). In agreement with this, we found that overexpressing either WT DED1 or the ded1-21-27/51-57 allele defective for eIF4A binding from a hc plasmid increased the growth rate of cdc33-1 cells (Figure 7A, rows 3–4 vs. 1. Importantly, however, the hc ded1-59-65/83-89 allele, defective for eIF4E binding in vitro, had no effect on growth of the mutant cells (Figure 7A, row 5 vs. 1). Western analysis verified that the mutant and WT ded1 alleles were overexpressed similarly in the cdc33-1 mutant (Figure 7B). These findings have two important implications. First, they provide strong evidence that the ded1-59-65/83-89 mutation impairs both a physical and functional interaction between Ded1 and eIF4E in cells. Second, they imply that overexpressing Ded1 partially suppresses the cdc33-1 mutation by enhancing interaction of the cdc33-1 product with Ded1 by mass action, presumably increasing the concentration of the eIF4F·Ded1 complex in which Ded1 functions most efficiently, rather than indirectly compensating for a reduction in eIF4F function (that should occur for all ded1 alleles).
Disruption of Ded1-eIF4A or eIF4E interactions impairs translation in vivo
We next investigated changes in bulk translation initiation upon disruption of Ded1-eIF4A or Ded1-eIF4E interactions by Ded1 NTD mutations, examining first the effects on total polysome assembly. Cells were treated with cycloheximide just prior to harvesting to prevent polysome run-off during isolation, and polysomes were resolved from 80S monosomes, free 40S and 60S subunits, and free mRNPs by sedimentation through sucrose density gradients. Both the ded1-ts,21-27/51-57 and ded1-ts,59-65/83-89 mutations, impairing Ded1 interactions with eIF4A or eIF4E, respectively, reduced the ratio of polysomes to monosomes (P/M), indicating a reduction bulk translation initiation, which was not significantly greater for one mutation versus the other (Figure 8A).
We further analyzed the functional defects in eIF4A- and eIF4E binding mutants by measuring expression of three luciferase (FLUC) reporter mRNAs harboring a Ded1-hypodependent synthetic unstructured 5’UTR harboring no stem-loop (no SL), or either cap-distal or cap-proximal SLs shown previously to confer Ded1-hyperdepence both in vivo (Sen et al., 2015) and in vitro (Gupta et al., 2018; Figure 8B). Relative to the ded1-ts parental mutant, introducing single- or double-cluster NTD mutations that impair binding to eIF4A or eIF4E, or control NTD mutations 14–20 and 40–47 with no effect on eIF4A/eIF4E binding, had little or no effect on expression of the reporter lacking a 5’UTR SL (Figure 8C, dark gray bars). The reporter with a cap-distal SL showed reduced expression relative to the no-SL construct in the ded1-ts parental strain (Figure 8—figure supplement 1, cols. 1–2), which was unaffected by the control NTD mutations; but was driven even lower by all of the mutations affecting eIF4A or eIF4E binding, with the greatest reductions seen for the two double substitutions ded1-ts,21-27/51-57 and ded1-ts,59-65/83-89 that eliminate, respectively, eIF4A or eIF4E binding to Ded1 (Figure 8C, light gray bars). Expression of the cap-proximal SL reporter was also reduced somewhat in the ded1-ts parental strain (Figure 8—figure supplement 1, col. 3 vs. 1), and was not further diminished by the control NTD mutations or the single cluster mutants defective for eIF4E binding (59–65 and 83–89), whereas the single cluster mutants defective for eIF4A binding (21–27 and 51–57) and both double-cluster mutants impairing eIF4A or eIF4E binding showed substantially reduced expression of this reporter, with the greatest reductions seen for the two double-cluster mutants (Figure 8C, white bars). Interestingly, overexpression of eIF4A conferred increased expression of the no SL and cap-distal reporters in the ded1-ts/21–27 mutant, predicted to exhibit partially impaired binding of eIF4A to Ded1, but not in the ded1-ts/21-27/51-57 or ded1-ts/59-65/83-89 strains expected to be fully defective for eIF4A binding, or for eIF4E binding, respectively (Figure 8—figure supplement 5). This supports the notion that the defect in reporter expression conferred by ded1-ts/21–27 involved impaired Ded1 association with eIF4A.
Finally, we verified that the decreased expression of the cap-proximal FLUC reporter in the Ded1 mutants results from impaired translation by examining the effects of the mutations on the polysome size distributions of the reporter mRNA, assayed by qRT-PCR of total mRNA isolated from each fraction of the density gradient used to resolve total ribosomal species, noting that a shift in mRNA abundance from larger to small polysomes, or from polysomes/monosomes to free mRNPs, indicates a reduction in the rate of translation initiation. In the parental ded1-ts mutant, the reporter mRNA is almost equally distributed among all gradient fractions (Figure 8D (ii), gray points). In the eIF4E-binding mutant ded1-ts,59-65/83-89, the proportion of reporter mRNA in the heavy polysome fractions is reduced, and the proportion in the smallest polysomes and monosomes is increased (Figure 8D (ii), orange points) relative to the mRNA distribution in the parental strain (Figure 8D (ii), grey points). Moreover, in the eIF4A binding mutant ded1-ts,21-27/51-57, the proportion of reporter mRNA in heavy polysomes is reduced and the proportion in free mRNP is elevated (Figure 8D (ii), green points) compared to that seen in the ded1-ts strain (Figure 8D (ii), grey points). The more extensive shift from polysomes to free mRNP observed for the eIF4A-binding mutant compared to the shift from larger to smaller polysomes/monosomes conferred by the eIF4E-binding mutant (Figure 8D (ii), green vs. orange) is consistent with the relatively greater reductions in cap-proximal SL reporter expression given by the set of three eIF4A-binding mutants versus the three eIF4E-binding mutants (Figure 8C, eIF4A(-) vs. eIF4E(-) mutants). This shift of the reporter mRNA from polysomes to free mRNP in the eIF4A-binding mutant or to smaller polysomes in the eIF4E-binding mutant is statistically significant (Figure 8—figure supplement 4). In contrast to the behavior of the reporter mRNA, the polysome distribution of native ACT1 mRNA was not substantially altered by either of the Ded1 NTD mutations (Figure 8D (i)), suggesting that Ded1’s interactions with eIF4A and eIF4E are relatively more important for the reporter mRNA harboring a stable SL structure compared to ACT1 mRNA. ACT1 mRNA was not found to be hyperdependent on Ded1 by ribosome profiling of a ded1 mutant (Sen et al., 2015). These results confirm that loss of eIF4A and eIF4E interactions by the Ded1 NTD lead to reduced translation initiation of a Ded1-hyperdependent reporter mRNA, as well as to decreased bulk translation initiation in vivo.
Assaying expression of the same LUC reporters, we found that the single amino acid mutations in the eIF4A binding region Y21A and R27A reduced expression of only the cap-distal SL (Y21A) or both SL reporters (R27A), and that the Y65A and W88A single-residue mutations in the eIF4E binding region reduced expression of both SL reporters, compared to the parental ded1-ts strain (Figure 8—figure supplement 1), thus supporting the importance of these individual residues in Ded1 NTD interactions with eIF4A and eIF4E in vivo.
We also provided evidence that eliminating both eIF4A and eIF4E binding simultaneously essentially inactivates the Ded1 NTD in promoting bulk translation as well as translation of Ded1-hyperdependent reporter mRNAs. As shown in Figure 8—figure supplement 2, the 21-27/51-57/59-65/83-89 quadruple-cluster mutation and the Δ2–90 deletion of the NTD introduced into otherwise WT DED1 conferred nearly indistinguishable reductions in bulk polysome assembly (panel A) and expression of both cap-proximal SL and cap-distal SL FLUC reporters (panel B). In both assays, the defects were quantitatively smaller than shown above for the double-cluster mutations in Figure 8A and 5C, which we attribute to the absence of the ded1-ts mutation in the parental and mutant alleles being compared in the current assays.
Finally, we obtained evidence that the effect of NTD mutations in exacerbating the effect of deleting the Ded1 CTD shown above in cell growth assays (Figure 4) could also be observed in the functional assays for polysome assembly and reporter mRNA expression. As shown in Figure 8—figure supplement 3A, the ded1-ΔC mutation analyzed above has little or no effect on polysome assembly on its own (cf. panels (i)-(ii)). However, ΔC clearly exacerbates the effects of both the 21-27/51-57 and 59-65/83-89 double-cluster mutations in the Ded1 NTD in reducing P/M ratios, with a relatively greater effect for the 21-27/51-57 mutation that eliminates eIF4A binding (cf. (iii)-(iv) and (v)-(vi)). Similarly, ded1-ΔC alone has only small effects on expression of the SL-containing FLUC reporters, but ΔC exacerbates the reductions in reporter expression conferred by 21-27/51-57 (Figure 8—figure supplement 3B, set four vs. sets 2 and 3) and by the 59-65/83-89 mutation (Figure 8—figure supplement 3B, set six vs. sets 2 and 5). These findings support our conclusion that eliminating eIF4G association with the Ded1 CTD imposes a relatively greater requirement for the Ded1 NTD interactions with eIF4A and eIF4E, either in forming or stabilizing the eIF4F·Ded1 complex or in stimulating Ded1 unwinding activity.
Disruption of Ded1-eIF4A or eIF4E interactions impairs 48S PIC assembly on a SL-containing mRNA in the purified system
The yeast reconstituted system provides a unique mechanistic view of translation initiation (Acker et al., 2007; Algire et al., 2002; Gupta et al., 2018; Mitchell et al., 2010), which allowed us previously to reconstitute the function of Ded1 in stimulating the rate of 48S PIC assembly on native mRNAs, and to demonstrate substantially greater rate-enhancement for mRNAs that harbor structured 5’UTRs that confer hyperdependence on Ded1 for efficient translation in vivo, compared to mRNAs with less structured 5’UTRs that are Ded1-hypodependent in cells. Moreover, we showed that deleting the N-terminal 116 residues of Ded1 (ΔNTD1-116) reduced the maximum rate of PIC assembly achieved at saturating levels of Ded1 (kmax) and increased the concentration of Ded1 required for the half-maximal rate (K1/2) for several mRNAs containing stable SL structures in the 5’UTRs (Gupta et al., 2018). As eliminating the entire N-terminal region did not distinguish between impairing binding to eIF4A, eIF4E, or eliminating some other stimulatory function of this region of Ded1, we sought to determine whether selectively impairing Ded1 interaction with eIF4A or eIF4E would impair Ded1 acceleration of 48S assembly on a SL-containing mRNA. Accordingly, we purified full-length (FL) WT Ded1, Ded1-ΔNTD1-116 and the two Ded1 variants harboring the double clustered substitutions that disrupt binding to eIF4A 21-27/51-57, or the single cluster substitution 59–65 that reduces binding to eIF4E, and compared them for acceleration of 48S PIC assembly on an mRNA (dubbed CP-8.1) containing the same cap-proximal SL present in the FLUC reporter mRNA analyzed above appended to the coding sequences and 3’UTR of of the Ded1-hypodependent native RPL41A mRNA. The three purified mutant proteins had ATPase activities similar to that of WT Ded1 (data not shown).
In agreement with previous results (Gupta et al., 2018), FL Ded1 substantially increased the kmax of 48S PIC formation on CP-8.1 mRNA by ~5 fold compared to the absence of Ded1, and deleting the NTD diminished the rate enhancement conferred by addition of Ded1 compared to no Ded1 in the reaction by ≈60% (Figure 9A, cols. 1–3; see Figure 9—figure supplement 1C for data summary). Interestingly, disrupting eIF4A binding to the NTD with the 21-27/51-57 double substitutions was comparable to the ΔNTD1-116 in reducing kmax, whereas the 59–65 substitution that affects eIF4E binding had no effect on the kmax (Figure 9A, cols. 3–5). The ΔNTD1-116 truncation also greatly increased the K1/2 for Ded1 on this mRNA (Figure 9B, cols. 1–2), as observed previously (Gupta et al., 2018); and both the 21-27/51-57 and 59–65 substitutions also increased the K1/2 for Ded1 to an extent ≈40% of that given by the ΔNTD1-116 (Figure 9B, cols. 2–4). These findings suggest that binding of eIF4A, but not eIF4E, to the Ded1 NTD is required for maximum acceleration of 48S PIC assembly on CP-8.1 mRNA, but that both eIF4A and eIF4E interactions decrease the amount of Ded1 required to achieve this stimulation, possibly by enhancing formation of the eIF4F·Ded1 complex (Gupta et al., 2018).
We showed previously that Ded1 also increases the rate of 48S PIC assembly on Ded1-hypodependent RPL41A mRNA, but to a lesser degree and at a much lower Ded1 concentration compared to Ded1-hyperdependent mRNAs such as CP-8.1 (analyzed above). As observed previously (Gupta et al., 2018), FL Ded1 increased the kmax for RPL41A mRNA by ~3 fold, and eliminating the Ded1 NTD by ΔNTD1-116 did not impair this stimulation (Figure 9—figure supplement 1A, cols. 2–3); however, ΔNTD1-116 increased the K1/2 for Ded1 on RPL41A mRNA by nearly 70-fold (Figure 9—figure supplement 1B, cols. 2–3). As expected, neither the 21-27/51-57 double substitution nor the 59–65 substitution altered the increase in kmax for RPL41A mRNA conferred by FL Ded1 (Figure 9—figure supplement 1A, cols. 4–5 vs. 2). While both substitutions increased the K1/2 for Ded1 compared to FL-Ded1 (~7 fold for 21-27/51-57 and ~4 fold for the 59–65 substitution), these increases were much smaller than the ~70 fold increase produced by ΔNTD1-116 (Figure 9—figure supplement 1B, cols. 3–4 vs. 2 cf. col.1;and Figure 9—figure supplement 1D, cols. 4–5 vs. 2 cf. col. 1). These last results suggest that strong interaction of either eIF4A or eIF4E with the Ded1-NTD is sufficient to greatly reduce the amount of Ded1 required for maximum acceleration of 48S PIC assembly on RPL41A mRNA. This contrasts with our findings on CP-8.1 mRNA, where eliminating either of the interactions of the Ded1-NTD with eIF4A and eIF4E conferred an increase in the Ded1 K1/2 only slightly smaller than that given by deleting the entire NTD. Thus, it appears that both interactions are needed simultaneously to enhance the function of the eIF4F-Ded1 complex on the more structured CP-8.1 mRNA, whereas each interaction can contribute independently and additively on the less structured RPL41A mRNA.
In previous studies, segments of the N-terminus of Ded1 have been shown to be required for rapid cell growth at a reduced temperature (Hilliker et al., 2011; Floor et al., 2016; Gao et al., 2016), robust translation of a reporter mRNA in cell extracts (Hilliker et al., 2011), the stimulatory effect of eIF4A on Ded1 unwinding activity in vitro (Gao et al., 2016), and wild-type acceleration of 48S PIC assembly on particular mRNAs in the yeast reconstituted system (Gupta et al., 2018). Ded1 physically interacts with eIF4E (Senissar et al., 2014), but the eIF4E binding site within Ded1 was unknown. Importantly, it was also unclear whether Ded1’s individual interactions with eIF4A or eIF4E are critical for Ded1 function in vivo in stimulating bulk protein synthesis and the translation of particular mRNAs with heightened Ded1-dependence conferred by 5’UTR structures. Finally, whereas interaction of the Ded1 CTD with eIF4G appears to enhance Ded1 unwinding function in vitro (Putnam et al., 2015; Gao et al., 2016), the ability of Ded1 to stimulate reporter translation in cell extracts (Hilliker et al., 2011) and 48S PIC assembly on particular mRNAs in a purified system (Gupta et al., 2018), it has been unclear whether this Ded1·eIF4G interaction is critical for Ded1 stimulation of translation in vivo. Our results fill in these important gaps in knowledge of how Ded1 stimulates translation initiation in living cells.
We have identified discrete, non-overlapping clusters of amino acids in the Ded1 NTD, as well as individual residues within these clusters, that appear to provide binding determinants for eIF4A or eIF4E, as their substitutions with alanine selectively reduce Ded1 binding to either GST-eIF4A or GST-eIF4E fusions in vitro. Binding determinants for eIF4A map between residues 21–27, including the highly conserved residue Arg-27, and also between residues 51–57, and appear to make independent, additive contributions to eIF4A binding. Binding determinants for eIF4E are located between residues 59–65, including Tyr-65, and between residues 83–89, including the highly conserved Trp-88, and appear to make concerted contributions to eIF4E binding. It is possible that additional binding determinants for eIF4E or eIF4A are located within the adjacent NTE extension of the helicase domain, which was not analyzed here, or within the Ded1 CTD (Figure 1D). Nevertheless, because the clustered NTD substitutions we identified selectively impair Ded1 binding to eIF4A or eIF4E in vivo at native levels of Ded1 expression, they provided us with the genetic tools needed to investigate whether Ded1’s individual interactions with eIF4A or eIF4E are crucial for robust Ded1 function in vivo.
Armed with these Ded1 variants, we obtained evidence that disrupting Ded1-NTD interactions with either eIF4A or eIF4E reduces cell growth and bulk translation initiation, and preferentially impairs translation of reporters harboring 5’UTR SL structures in vivo. The Ded1 substitutions that impair interaction with eIF4A examined in combination with the ded1-ts mutation conferred a greater reduction in cell growth and an equal or somewhat greater impairment of the SL-containing reporters, but not a greater reduction in bulk polysomes, compared to the substitutions disrupting eIF4E binding to the Ded1 NTD. However, when introduced into otherwise WT Ded1, or the Ded1-ΔC variant, the substitutions perturbing eIF4A binding consistently impaired growth and both bulk and reporter translation more so than those impacting eIF4E binding. Thus, on balance, eIF4A interaction appears to be relatively more important than eIF4E interaction with the Ded1 NTD for strong translation initiation in vivo.
It was important to provide additional evidence that the Ded1 NTD substitutions impair translation initiation in vivo because they selectively impair Ded1 interactions with eIF4A or eIF4E rather than participating in some other aspect of Ded1 function. This was achieved for the substitutions that impair eIF4A binding by showing that overexpressing eIF4A mitigates the growth defects of NTD mutants 21–27 or 51–57, which only partially impair eIF4A binding in vitro, but not of the double mutant 21-27/51-57 that appears to be incapable of binding eIF4A and, hence, should be refractory to a restoration of Ded1-eIF4A association by mass action. Nor did overexpressing eIF4A suppress the growth defects conferred by the 59-65/83-89 mutations that impair Ded1 binding to eIF4E. We used a different genetic approach to confirm that the latter NTD substitutions impair translation in vivo by diminishing Ded1-eIF4E association, by showing that overexpressing the 21-27/51-57 Ded1 variant, impaired for eIF4A association, behaves like overexpressed WT Ded1 and mitigates the phenotype of the eIF4E mutant cdc33-1, whereas overexpressing the 59-65/83-89 Ded1 variant selectively defective for eIF4E binding cannot rescue cdc33-1 cells. While we cannot completely eliminate the possibility that the NTD mutations impair cell growth and translation in vivo by affecting some other aspect of Ded1 function with indirect consequences, these genetic suppression results provide confidence that Ded1-NTD interactions with eIF4A and eIF4E are physiologically important. It is noteworthy that the quadruple-cluster substitution mutation 21-27/51-57/59-65/83-89 that eliminates binding to both eIF4A and eIF4E confers a defect in cell growth greater than that seen for the two double-cluster substitutions that impair binding to only eIF4A or eIF4E, which is equivalent to that given by deleting the entire NTD (Δ2–90). These findings strongly suggest that eIF4A/eIF4E binding represents the crucial in vivo function of the Ded1 NTD.
The importance of the Ded1 CTD and its ability to interact with eIF4G in promoting translation initiation in vivo has been unclear, as its removal did not reduce growth in nutrient-replete cells; and while a deletion spanning the junction between the helicase core domain and the relatively conserved CTE was found to exacerbate the growth defects of two NTD mutations, a similar finding was not reported for a mutation affecting the more distal CTD domain (Hilliker et al., 2011). Here, we found that truncating the Ded1 CTD impairs cell growth, bulk polysome assembly, and translation of reporter mRNA in vivo only in Ded1 variants additionally impaired for their association with eIF4A or eIF4E via the Ded1 NTD. In view of recent findings that the last 14 residues of the CTD are crucial for Ded1 binding to eIF4G in vitro (Aryanpur et al., 2019), our genetic findings imply that the interactions of Ded1 with each of the three subunits of eIF4F make independent, additive contributions to formation of the eIF4F·Ded1 complex and attendant stimulation of Ded1 helicase functions in promoting translation initiation. Interestingly, truncating the CTD to eliminate its ability to bind eIF4G confers resistance to cell growth inhibition by rapamycin, implicating the Ded1-CTD/eIF4G interaction in TORC1-mediated down-regulation of translation during nutrient starvation (Aryanpur et al., 2019) beyond its stimulatory function in nutrient-replete cells.
Using the reconstituted yeast system, we obtained evidence that individually disrupting Ded1-NTD interactions with either eIF4A or eIF4E impaired the ability of Ded1 to accelerate PIC assembly on a reporter mRNA harboring a cap-proximal SL. As we observed for a cap-proximal FLUC reporter in cells, Ded1 interaction with eIF4A was important for 48S PIC assembly on a cap-proximal SL reporter mRNA in vitro, as the Ded1 variant selectively impaired for eIF4A binding (21-27/51-57) reduced the maximum rate of PIC assembly (kmax) and also increased the amount of that variant required to achieve half-maximal rate stimulation (K1/2) compared to WT Ded1. The Ded1 variant impaired for binding eIF4E (59-65) increased the Ded1 K1/2 by a comparable amount, but did not reduce the kmax for the cap-proximal SL reporter. While this might suggest a lesser requirement for Ded1 interaction with eIF4E versus eIF4A for rapid PIC assembly on this structured mRNA, the single-cluster variant 59–65 analyzed in vitro is not impaired for translation of the cap-proximal FLUC reporter in vivo, and we were unable to purify and analyze the double-cluster mutant 59-65/83-89 lacking both eIF4E binding determinants, which is compromised for translation of the cap-proximal promoter in vivo.
Interestingly, for the Ded1-hypodependent mRNA RPL41A, containing a 5’ UTR of only 22nt lacking recognizable secondary structure, the Ded1 NTD1-116, and hence interaction with both eIF4A and eIF4E, is dispensable for the modest ~2.5 fold increase in kmax afforded by Ded1. Importantly, however, the ΔNTD1-116 variant (incapable of eIF4A/eIF4E interactions) requires an ~70 fold higher concentration compared to WT Ded1 to achieve the same half-maximal acceleration (K1/2) on this mRNA. The 21-27/51-57 and 59–65 variants accelerate PIC assembly on RPL41A mRNA at ~10–20 times lower concentrations compared to ΔNTD1-116, indicating that interaction with either eIF4E or eIF4A by these substitution mutants is sufficient to increase the efficiency of Ded1 function on this mRNA compared to the absence of both interactions. For CP-8.1 mRNA, by contrast, interaction with either eIF4E or eIF4A by the two aforementioned Ded1 variants confers only a small benefit, decreasing the K1/2 by ~2 fold, whereas having both interactions intact in WT Ded1 lowers the K1/2 by 7.6-fold, compared to ΔN1-116. Thus, while Ded1 interactions with eIF4A and eIF4E are important for Ded1 acceleration of PIC assembly on both mRNAs, the unstructured RPL41A mRNA appears to have a relatively smaller requirement for a full set of contacts between Ded1 and eIF4A/eIF4E in order for Ded1 to function at low concentrations. Moreover, CP-8.1 additionally requires Ded1 contacts with eIF4A (impaired by substitutions 21-27/51-57) to overcome the SL structure and achieve maximum acceleration, even at high Ded1 concentrations.
One way to account for these differences between the RPL41A and CP-8.1 mRNAs, depicted in the model shown in Figure 9C, would be to propose that the Ded1 interactions with the subunits of the eIF4F complex lowers the concentration of Ded1 required for its recruitment to the capped mRNA 5’ end where it can unwind structures that impede PIC attachment or scanning to the start codon. This enhancement would apply to both unstructured and structured mRNAs, but structured mRNAs might require a more stable association between Ded1 and eIF4F for maximum Ded1 recruitment and, hence, be relatively more dependent on having both eIF4A and eIF4E contacts with the Ded1 NTD intact. Unwinding stable SL structures might additionally require the enhancement of Ded1 unwinding activity conferred by its interaction with eIF4A (Gao et al., 2016) to achieve maximum acceleration of PIC attachment or scanning (Figure 9C).
Together, our findings indicate that the Ded1 NTD interacts directly with eIF4E and eIF4A via adjacent, non-overlapping segments of the NTD, and that these interactions, in concert with the Ded1-CTD interaction with eIF4G, make independent, additive contributions to Ded1 function in stimulating translation initiation in vivo. As summarized schematically in Figure 9D, in all of our in vivo assays of cell growth and bulk or reporter mRNA translation, eliminating Ded1 interaction with eIF4G by deleting the Ded1 CTD had a less severe impact than did impairing eIF4A or eIF4E binding to the Ded1 NTD, and the eIF4A interaction with Ded1 appeared to be the most important overall. Envisioning all of these interactions occurring simultaneously on an mRNA suggests that they should serve to tether Ded1 tightly to the activated eIF4F·mRNA complex and focus its helicase activity on the 5’UTR to unwind structures that impede PIC attachment or subsequent scanning (Figure 9C). Consistent with previous in vitro findings that interaction with eIF4A increases Ded1 unwinding activity (Gao et al., 2016), our results here in the reconstituted system suggest that the Ded1-NTD interaction with eIF4A is particularly important for enhancing Ded1 unwinding of the SL structure in CP-8.1 mRNA. It remains to be determined whether the Ded1 interaction with eIF4E serves primarily to stabilize formation of the eIF4F·Ded1 complex and localize it to mRNA 5’ ends, or whether, it too stimulates Ded1 unwinding activity. In summary, we envision that Ded1-NTD interactions with both eIF4A and eIF4E, and Ded1-CTD binding to eIF4G, all help to assemble and stabilize the eIF4F-Ded1 complex at the 5’ ends of mRNAs, which enhances initiation of nearly all mRNAs, whereas the Ded1-NTD/eIF4A interaction is additionally important to stimulate Ded1 unwinding of strong secondary structures in mRNA 5’UTRs (Figure 9C). Given the much greater abundance of eIF4A compared to eIF4E and eIF4G (von der Haar and McCarthy, 2002), the stimulation of Ded1 unwinding by eIF4A might also involve eIF4A molecules not tethered to eIF4F at the cap structure.
Materials and methods
Plasmids and yeast strainsRequest a detailed protocol
All plasmids employed in this study are listed in Table 1. To create plasmids for bacterial expression of GST fusions to eIF4A1 and eIF4E, TIF1 and CDC33 coding sequences were amplified by PCR from the genomic DNA of WT yeast strain BY4741 (using primers listed in Table 2) and inserted between the BamHI and XhoI sites of pGEX4T1. pET-C-Ded1 cut with NdeI and XhoI was used to construct pSG49-pSG51 by inserting fragments encoding Ded1 residues 93–604 (pSG49), residues 1–561 (pSG50), or residues 93–561 (pSG51), PCR-amplified from pET-C-Ded1. Plasmids pSG52-pSG75 were derived from pET-C-Ded1 using the Agilent QuikChange Lightning Mutagenesis kit, according to the vendor’s instructions, as were pSG76-pSG81 by mutagenesis of pET-N-Ded1. pSG1was constructed by inserting a fragment containing the DED1 promoter (beginning 331 nt upstream of the AUG), entire coding sequence, coding sequence for the myc13 epitope, and the ADH1 terminator, PCR-amplified from the genomic DNA of yeast strain H3666, between into the SphI and SacI sites of LEU2/CEN4/ARS1 vector YCplac111. pSG2, containing ded1-ts-myc was derived from pSG1 by mutagenesis with Agilent QuikChange Lightning Mutagenesis kit to introduce the T408I/W253R substitutions. pSG27-pSG43 were derived from pSG1; and pSG3-pSG26 were derived from pSG2, by QuikChange mutagenesis. pSG44-pSG46 were similarly derived from p4504/YEplac195-DED1.
All yeast strains employed in this study are listed in Table 3. Novel strains SGY1-SGY43 harboring plasmid pSG1-pSG43, were constructed by plasmid shuffling using 5-fluoroorotic acid (5-FOA) (Boeke et al., 1987) from strain yRP2799, as follows. Transformants of yRP2799 containing the relevant LEU2 pSGY plasmid were selected on SC-Leu-Ura, patched on medium of the same composition, and replica-plated to SC-Leu containing 1 mg/ml 5-FOA. After 48–72 hr at 30°C, Ura- segregants were purified from patches able to grow on 5-FOA medium by streaking for single colonies on SC-Leu.
Yeast growth dilution-spot assaysRequest a detailed protocol
Yeast strains were cultured in SC-Leu to A600 of ~1.0, dilutions of 10−1, 10−2, 10−3, and 10−4 were prepared in sterile water, and 5 μL aliquots of undiluted and diluted yeast cells were spotted on SC-Leu medium and incubated at the temperatures indicated in the figure legends.
Purification of recombinant GST fusion proteins expressed in E. coliRequest a detailed protocol
Agilent BL21-CodonPlus (DE3)-RIPL competent E. coli were transformed with pGEX4T1 or its derivatives containing the TIF4631, TIF1 or CDC33 coding sequences. Transformants were grown in 500 ml LB+Amp+Cam medium at 37°C to A600 of ~0.5 and protein expression induced by adding IPTG to 1 mM and incubating at 18°C overnight with agitation. Harvested cells were washed with 50 ml phosphate-buffered saline (PBS) and lysed by sonication in the presence of 50 μg/mL lysozyme and 10% glycerol. Lysates were treated with 10% Triton X-100 at 4°C and cleared by centrifugation at 10,000xg. 500 μL of GE Healthcare Glutathione Sepharose 4B beads were added per 20 mL of lysate and incubated with rotation overnight at 4°C. The beads were washed twice with 5 ml PBS in 10% glycerol and treated with 5000 gel units of NEB Micrococcal Nuclease in the presence of 2 mM calcium chloride in 1 ml PBS. The reaction was stopped by addition of EDTA to 5 mM, followed by washing the beads with 1 ml of 500 mM sodium chloride in PBS/glycerol. The beads were washed two more times with 1 ml PBS in 10% glycerol and the washed beads were stored at −80°C. SDS-polyacrylamide gel electrophoresis (SDS-PAGE), followed by Coomassie Blue staining, was employed to estimate the amounts of GST-tagged proteins bound to the glutathione-agarose beads by comparison to known amounts of bovine serum albumin.
In vitro translation of Ded1 polypeptidesRequest a detailed protocol
Promega TNT Quick Coupled Transcription/Translation System was employed for in vitro translation of Ded1 proteins for GST pull-down assays. Perkin Elmer EasyTag L-[35S]-Methionine was used for radioactive labeling following the vendor’s instructions.
In vitro GST pull down assaysRequest a detailed protocol
GST pull down reactions were conducted as follows. Aliqouts of 10 μL of GST or GST-tagged bait proteins bound to glutathione-agarose beads were combined with 8 μL of pull-down buffer (40 mM Tris, pH 8.0, 0.01% IGEPAL CA630, 2 mM DTT, 50 mM NaCl, 20% glycerol, and 5 mM MgCl2), 0.5 μL of 5 mg/ml bovine serum albumin, 0.5 μL of ThermoFisher Scientific RNase A/T1 mix and 1 μL of [35S]-labeled Ded1 protein. The reactions were incubated at 4°C with end-over-end rotation overnight. The beads were washed three times with 30 μL of pull-down buffer without glycerol and proteins eluted with 20 μL 15 mM Glutathione [pH 8.0]. The input proteins and eluates were resolved by SDS-PAGE and visualized by fluorography, as follows. Gels were fixed in 50% methanol and 15% acetic acid, stained with Coomassie Blue, treated with Amersham Amplify Fluorographic Reagent, dried under vacuum and exposed to X-ray film for 18–72 hr at −80°C. After developing, the films and gels were scanned, and band intensities analyzed by NIH ImageJ software. Pull down efficiency was calculated as intensity of pulled down band divided by the corresponding input band intensity and converted to percentages. For statistical analyses, three or four replicates were performed. Unpaired student’s t test was employed to determine p-values. GraphPad software was used to graph the data as dot plots.
Coimmunoprecipitation and western blots using yeast WCEsRequest a detailed protocol
For coimmunoprecipitation analysis, transformants of H3446 containing the relevant plasmid-borne DED1-myc alleles or empty vector were cultured in 100 mL of SC-Leu-Trp to A600 of ~0.8, harvested by centrifugation, washed with coimmunoprecipitation (CoIP) buffer (100 mM Tris-HCl pH 7.5, 100 mM sodium chloride, 0.1% NP-40, 1 mM DTT, 1 mM PMSF, 1 × Complete Protease Inhibitor Mix tablets without EDTA [Roche]) and lysed by vortexing with glass beads. Lysates were cleared by centrifugation and total protein amount determined colorimetrically using BioRad Bradford Reagent. The WCEs extracts were diluted to 5 mg/mL in CoIP buffer and aliquots of 1 mg (200 μL) were immunoprecipitated with 5 μg Roche anti-myc antibody (clone 9E10). After 2 hr of rotation at 4°C, 50 μL ThermoFisher Scientific Dynabeads Protein G were added and rotation continued for 2 hr more. Using a magnetic rack, the beads were washed three times with 150 μL CoIP buffer. The beads were resuspended in 100 μL 2x Laemmli buffer and boiled for 5 min. SDS-PAGE and Western blot were employed to detect the immunoprecipitated proteins, using the following antibodies: mouse monoclonal anti-HA antibody (12C5; Roche Cat# 11 666 606 001), mouse monoclonal anti-c-Myc antibody (9E10; Roche Cat# 11 667 203 001), rabbit polyclonal anti-eIF4A/Tif1 (kindly provided by Patrick Linder), rabbit polyclonal anti-eIF4E/Cdc33 (kindly provided by J.E.G. McCarthy), and rabbit polyclonal anti-Ded1 antibody (kindly provided by Dr. Tien-Hsien Chang). The immune complexes were visualized by enhanced chemiluminescence.
For Western blot analysis of yeast WCEs, trichloroacetic acid (TCA) precipitation was employed to extract total protein (Reid and Schatz, 1982), extracts were resolved by. SDS-PAGE, and Western blots were probed using the antibodies listed above, as well as rabbit polyclonal anti-Hcr1 antibodies (Valásek et al., 2001).
Luciferase reporter assaysRequest a detailed protocol
Two-ml cultures of yeast transformants harboring the relevant reporter plasmids were harvested by centrifugation and the cell pellets were washed with 500 μL PBS and lysed by vortexing with glass beads in 200 μL PBS supplemented with 1 × Complete Protease Inhibitor Mix tablets without EDTA [Roche]. Lysates were cleared by centrifugation, diluted 1:100 in PBS supplemented with 1 × Complete Protease Inhibitor Mix tablets without EDTA and luciferase was assayed using Promega Luciferase Assay System and a luminometer. Total protein concentration was measured colorimetrically using Bradford Reagent (BioRad) and known amounts of bovine serum albumin as standards. Luciferase units were normalized by the total protein amounts.
Polysome fractionation and analysis of mRNAsRequest a detailed protocol
For analyzing polysomes profiles, 200 mL of cells were cultured in the appropriate medium at 30°C and shifted to 36°C for 3 hr or to 15°C for 1 hr, and harvested at A600 ≈ 1. Cells were treated with 50 μg/ml cycloheximide for 5 min prior to harvesting. WCEs were prepared by resuspending the cell pellet with an equal volume of breaking buffer (20 mM Tris-HCl, pH 7.5, 50 mM KCl, 10 mM MgCl2, 1 mM dithiothreitol [DTT], 5 mM NaF, 1 mM phenylmethylsulfonyl fluoride [PMSF], 1 × Complete Protease Inhibitor Mix tablets without EDTA [Roche], 1 U/μl SUPERase-In RNase inhibitor) and vortexing with glass beads, followed by two cycles of centrifugation for 10 min at 15,000 rpm at 4°C. 20 A260 units of cleared lysate were resolved on 10–50% (w/w) sucrose gradients by centrifugation at 39,000 rpm for 160 min at 4°C in a Beckman SW41Ti rotor. Gradients were fractionated with a Brandel Fractionation System with continuous monitoring at 254 nm with an ISCO UV detector. Fractions (0.7 mL) were precipitated overnight at −20°C by adding 1.5 volumes of RNA precipitation mix (95% ethanol, 5% sodium acetate pH 5.2), and centrifuged at 15,000 rpm for 30 min. 5 ng of ‘spike-in RNA’ was added to each fraction to control for differences in RNA recovery: a mixture of in vitro transcribed capped Bacillus subtilis mRNAs (Arava et al., 2003): 80 pg/µL lysA (prepared from plasmid pGIBS-LYS; ATCC#87482), 160 pg/µl trpCDEF (prepared from plasmid pGIBS-TRP; ATCC#87485), and 320 pg/µl of pheB (prepared from plasmid pGIBS-PHE; ATCC #87483). This mixture of in vitro transcribed mRNAs was a kind gift from Dr. Neelam Sen (Sen et al., 2019). Pellets were washed in 1 mL cold 80% ethanol, dried in a speed vacuum, resuspended in 100 µL TE buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA) and treated with 10 Kunitz units of DNase I. Qiagen RNEasy Mini kit was used to extract RNA and resuspended in 25 μL RNase-free water.
For RT-qPCR analysis of mRNA abundance in each gradient fraction, reverse transcription was carried out using SuperScript III First-Strand cDNA Synthesis SuperMix (Invitrogen) and 2 μL RNA purified from each gradient fractions. qPCR was carried out using Brilliant III Ultra-Fast SYBR Green Master Mix (Agilent) in a Mx3000P System (Stratagene) and the oligonucleotide pairs listed in Table 2. Normalization and analyses were performed as described in Chiu et al., 2010 and Sen et al., 2015.
mRNA recruitment assays in the yeast reconstituted system
Preparation and purification of mRNAs, charged initiator tRNA and translation initiation factorsRequest a detailed protocol
Plasmids for in vitro run-off mRNA and initiator tRNA transcription are described in Acker et al., 2007; Mitchell et al., 2010; Gupta et al., 2018. RPL41A mRNA represents the full-length native transcript. CP-8.1 mRNA has an unstructured 5’UTR comprised of CAA repeats with a stem-loop inserted five nt from the cap appended to the body of RPL41A. The mRNAs were transcribed, purified and capped as described in Gupta et al., 2018. Initiator tRNA was transcribed, methionylated and purified as described previously (Yourik et al., 2017). mRNAs were capped (m7GpppG) in vitro using vaccinia virus D1/D12 capping enzyme with either α-32P radiolabeled GTP (Perkin Elmer) or unlabeled GTP (for pulse-chase) (Mitchell et al., 2010). Eukaryotic initiation factors, 40S ribosomal subunits, and WT Ded1 and its mutant derivatives were expressed and purified as described previously (Acker et al., 2007; Mitchell et al., 2010; Munoz et al., 2017; Gupta et al., 2018).
The Ded1 proteins bearing N-terminal His6-tags (Genscript) were expressed from the appropriate pET22b vectors in E. coli strain BL21(DE3) RIL CodonPlus cells (Agilent) by culturing cells in LB medium at 37°C to A600 of ~0.5, cooled to 20°C, and induced by addition of IPTG to 0.5 mM for 16 hr. Cells were harvested and resuspended in 35 mL lysis buffer (10 mM HEPES-KOH, pH-7.4, 200 mM KCl, 0.1% IGEPAL CA-630, 10 mM imidazole, 10% glycerol, 10 mM 2-mercaptoethanol, and cOmplete protease inhibitor cocktail (Roche)) and lysed using a French Press. The cell lysate was treated with DNaseI (1 U/mL) for 20 min on ice and the KCl concentration was adjusted to 500 mM. His6-Ded1 proteins were affinity-purified using a nickel column (5 ml His-Trap column, GE Healthcare). Fractions containing the Ded1 proteins were collected, the glycerol concentration was adjusted to 30%, and the Ded1 was further purified by phosphocellulose chromatography (P11, Whatman). Purified Ded1 proteins were dialyzed against dialysis buffer (10 mM HEPES-KOH, pH 7.4, 200 mM KOAc, 50% Glycerol, 2 mM DTT) and stored at −80°C.
mRNA recruitment kineticsRequest a detailed protocol
mRNA recruitment kinetics were performed using a native gel shift assay as described previously (Mitchell et al., 2010; Yourik et al., 2017). This assay determines the apparent rates (kapp) and maximal rates (kmax) of recruitment as well as the concentration of a factor required to achieve half-maximal rate of recruitment (K1/2). Briefly, PICs were assembled with 300 nM eIF2, 0.5 mM GDPNP·Mg2+, 200 nM Met-tRNAiMet, 1 µM eIF1, 1 µM eIF1A, 300 nM eIF5, 300 nM eIF4B, 300 nM eIF3, 75 nM eIF4E·eIF4G, 7 µM eIF4A (15 µM for SFT2 mRNA) and 30 nM 40S subunits in 1X Recon buffer (30 mM HEPES-KOH, pH 7.4, 100 mM KOAc, 3 mM Mg(OAc)2, and 2 mM DTT). The concentration of Ded1 was varied in the reactions from 0 to 1000 nM for WT Ded1 and 0–6000 nM for the Ded1 variants. Complexes were assembled at 26°C for 10 min and reactions were initiated by addition of 15 nM 32P-m7G capped mRNA and 5 mM ATP·Mg2+. Reactions were quenched by addition of 600–750 non-radiolabeled m7G-mRNA at appropriate times (Mitchell et al., 2010; Yourik et al., 2017) and 48S PICs were separated from the free mRNA on a 4% non-denaturing PAGE gel. The fraction of the mRNA recruited to the 48S PIC at each time-point was calculated using ImageQuant software (GE Healthcare). Data were fitted with a single exponential rate equation and hyperbolic equations (KaleidaGraph software (Synergy)) to determine the apparent rates (kapp) and maximal rates (kmax) of recruitment as well as the concentration of a factor required to achieve half-maximal rate of recruitment (K1/2). Bar-graph data representations were prepared using Prism 7 (GraphPad).
Multiple sequence alignmentsRequest a detailed protocol
T-Coffee (www.ebi.ac.uk/Tools/msa/tcoffee) was used to align Ded1 amino acid sequences from fungal and animal species. Saccharomyces Genome Database (https://www.yeastgenome.org/) was the source of Ded1 sequences from the genus Saccharomyces. Other sequences were retrieved from NCBI Protein (https://www.ncbi.nlm.nih.gov/protein) and UniProt (https://www.uniprot.org/). The results were reformatted with MView (www.ebi.ac.uk/Tools/msa/mview) and WebLogo (weblogo.berkeley.edu).
All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures 9 and 9-supplement 1.
Reconstitution of yeast translation initiationMethods in Enzymology 430:111–145.https://doi.org/10.1016/S0076-6879(07)30006-2
The DEAD-box RNA helicase Ded1 has a role in the translational response to TORC1 inhibitionMolecular Biology of the Cell 30:2171–2184.https://doi.org/10.1091/mbc.E18-11-0702
5-Fluoroorotic acid as a selective agent in yeast molecular geneticsMethods in Enzymology 154:164–175.https://doi.org/10.1016/0076-6879(87)54076-9
The C-terminal region of eukaryotic translation initiation factor 3a (eIF3a) promotes mRNA recruitment, scanning, and, together with eIF3j and the eIF3b RNA recognition motif, selection of AUG start codonsMolecular and Cellular Biology 30:4415–4434.https://doi.org/10.1128/MCB.00280-10
The novel ATP-binding cassette protein ARB1 is a shuttling factor that stimulates 40S and 60S ribosome biogenesisMolecular and Cellular Biology 25:9859–9873.https://doi.org/10.1128/MCB.25.22.9859-9873.2005
Autoinhibitory interdomain interactions and Subfamily-specific extensions redefine the catalytic core of the human DEAD-box protein DDX3Journal of Biological Chemistry 291:2412–2421.https://doi.org/10.1074/jbc.M115.700625
The scanning mechanism of eukaryotic translation initiationAnnual Review of Biochemistry 83:779–812.https://doi.org/10.1146/annurev-biochem-060713-035802
The mechanism of eukaryotic translation initiation and principles of its regulationNature Reviews Molecular Cell Biology 11:113–127.https://doi.org/10.1038/nrm2838
Eukaryotic translation initiation factors 4G and 4A from Saccharomyces cerevisiae interact physically and functionallyMolecular and Cellular Biology 19:5557–5564.https://doi.org/10.1128/MCB.19.8.5557
Yeast eukaryotic initiation factor (eIF) 4B enhances complex assembly between eIF4A and eIF4G in vivoThe Journal of Biological Chemistry 228:2340–2354.https://doi.org/10.1074/jbc.M112.398537
RGG motif proteins: modulators of mRNA functional statesCell Cycle 11:2594–2599.https://doi.org/10.4161/cc.20716
Import of proteins into mitochondria. Yeast cells grown in the presence of carbonyl cyanide m-chlorophenylhydrazone accumulate massive amounts of some mitochondrial precursor polypeptidesThe Journal of Biological Chemistry 257:13056–13061.
The Ded1/DDX3 subfamily of DEAD-box RNA helicasesCritical Reviews in Biochemistry and Molecular Biology 49:343–360.https://doi.org/10.3109/10409238.2014.931339
Nahum SonenbergReviewing Editor; McGill University, Canada
James L ManleySenior Editor; Columbia University, United States
In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.
[Editors' note: this paper was reviewed by Review Commons.]
The authors present convincing evidence that the interactions of eIF4A and eIF4E with Ded1 are critical in vivo in yeast. They delineated the locations in Ded1 of the binding sites for eIF4A and eIF4E. They provided strong evidence for the function of Ded1 in promoting translation in vivo and in vitro in a purified system. This study raises the interesting question as to why the mammalian Ded1 homolog, DDX3X is involved in many functions other than translation in the cell, such as miRNA biogenesis, mRNA nucleo-cytoplasmic transport, pre-mRNA splicing, and others, while in yeast it functions strictly in translation.https://doi.org/10.7554/eLife.58243.sa1
Reviewer #1 (Evidence, reproducibility and clarity):
The manuscript by Gulay et al. describes a study into the role of contacts between the RNA helicase Ded1 and components of the translation initiation factor 4F complex during eukaryotic protein synthesis. Using the purified yeast factors and targeted mutagenesis, the authors delineate binding sites for eIF4E and eIF4A in the Ded1 N-terminal domain. They then study the importance of these binding sites for growth and translation initiation in yeast in vivo, and in a reconstituted in vitro system, showing that both sites enhance the functioning of Ded1 during translation initiation, with subtly different effects.
In my view the study is overall expertly done and relies on a broad portfolio of techniques that explores the importance of the two binding sites from a variety of angles. I think the discussion and the conclusions drawn are quite conservative and certainly do not overinterpret the data, however I see it as a downside that the discussion so strictly adheres to a static view of a fully formed eIF4F complex as the substrate for Ded1 binding, as exemplified by the scheme in Figure 9C. On a number of counts, the authors' data suggest a much more flexible process, and a discussion that reflects this could enhance the manuscript. The first four points below make specific suggestions around which this could be based.
1) Figure 5 suggests that mutations in the eIF4E binding site reduce interaction with eIF4E without reducing the interaction with eIF4G. Since the eIF4E:eIF4G interaction is very stable, this makes it unlikely that Ded1 interacts with a fully formed eIF4F complex (otherwise the pull-down of eIF4G should also be affected). Moreover, Ded1 was never detected in the initial cap-pull downs which led to the characterisation of eIF4F, again arguing that its interaction may be restricted to particular times or states of the initiation machinery.
This is a good point and we have revised the text to include the possible interpretation that Ded1 can interact separately with the individual subunits of eIF4F in addition to the intact complex. However, this would be odds with the expectation that the majority of Ded1 is associated with eIF4F in cells, based on estimates of the binding constant for Ded1 association with eIF4F and the cellular concentrations of these factors (Gao et al., 2016). Rather, it seems plausible that weakening the association of Ded1 with eIF4E would lead to a specific reduction in eIF4E coimmunoprecipitation with Ded1-myc owing to dissociation of eIF4E from eIF4G during the extensive washing steps involved in the experiment, notwithstanding the stable interaction of eIF4E with eIF4G. The absence of Ded1 in the initial cap pull-down experiments that recovered eIF4F can be explained by the known high off-rate of Ded1 from eIF4F (Gao et al., 2016).
2) The authors' data contain some evidence for regulatory interactions within Ded1. First, deletion of the CTD appears to enhance eIF4A binding but reduce eIF4E binding (Figure 1C). I note that the magnitude of the increase in eIF4A binding is similar to the decrease in eIF4E binding, yet the authors describe the first as "comparable" but the second as "reduced" – it would be useful to see statistics here.
We had indeed neglected to add the statistics to Figures 1C-D, which we rectified by revising these panels of Figure 1. While the reduction in Ded1 binding to GST-eIF4E is significantly reduced for the Ded1-ΔC variant (P=0.03); the apparent increase in Ded1-ΔC binding to GST-eIF4A is not significant (P=0.10), which underlies our conclusion that ΔC impairs binding to eIF4E but not eIF4A.
Second, I note that the 14-20 mutant appears to suppress the ded1-ts slow growth phenotype (Figure 3B, lane 3 at 34C) and also shows a slight increase in eIF4E binding (Figure 2C).
We find that this apparent suppression was not evident in several independent transformants and added this information to the text.
The apparent increase in binding of Ded1 variant 14-20 to GST-eIF4E is not significant (P=0.08).
3) Figure 8C suggests distinct effects of Ded1 binding to eIF4A (important for translating transcripts with both cap-proximal and cap-distal stem loops) and eIF4E (only important for transcripts with cap-distal stem loops). This is not consistent with the model in Figure 9C, where the different interactions only contribute additive binding contacts with eIF4F.
Figure 8C shows that impairing Ded1 binding to either eIF4E (with Ded1-59-65/83-89 substitutions) or eIF4A (with 21-27/51-57 substitutions) significantly impairs translation of both cap-proximal and cap-distal SL reporters, just to a lesser extent for the cap-proximal reporter on weakening eIF4E-Ded1 interaction with Ded1-59-65/83-89. This difference in magnitude of the translation defects is consistent with our model in Figure 9C if we stipulate that impairing the Ded1-eIF4E interaction by the 59-65/83-89 substitutions has a smaller impact on assembly of the eIF4F-Ded1 complex compared to that conferred by the Ded1 21-27/51-57 substitutions and that robust translation of the cap-proximal SL reporter is more dependent on eIF4F-Ded1 association compared to the cap-distal reporter. Text to this effect has been added to the discussion of the model in Figure 9.
4) The distinction between effects on attachment of Ded1 to eIF4F vs helicase activity is only superficially discussed. Figure 9A and B show that both eIF4E and eIF4A are important for attachment of Ded1 to eIF4F (as both binding mutants affect the K1/2), but only eIF4A is important for stem loop unwinding (as only the eIF4A binding site affects the Kmax). This is discussed by the authors. I think the fact that on an unstructured stem loop both binding site mutants still affect the K1/2 but not the Kmax further supports this – presumably this means that the Ded1/eIF4F interaction is always more efficient when supported by the additional eIF contacts, whereas Ded1 helicase activity is sufficient on its own on unfolded constructs but requires support from eIF4A on stem-loop containing transcripts.
We thank the reviewer for this insight, and we have added new Figure 9C and explanatory text to represent this interpretation.
5) A last point where clarification would be useful is on the polysome profiles in Figure 8. Translation initiation defects often lead to the appearance of a shoulder on the monosome peak, which is usually interpreted as mRNAs with one translating ribosome and initiating 40S subunit (e.g.PMID 12471154 uses this extensively). None of the profiles shown in this study show such a shoulder, can the authors explain why this is?
The absence of halfmers can be explained if reducing Ded1 function by impairing its association with eIF4F primarily reduces attachment of PICs to the mRNA or impedes the migration of scanning PICs to the AUG codon for assembly of stable 48S PICs (with Met-tRNAi base paired to AUG) that can withstand the hydrostatic pressures of sedimentation through sucrose. Indeed, our recent 40S profiling of ded1 mutants indicates the occurrence of both such defects in PIC attachment and scanning.
Moreover, although the polysome parts of the profiles clearly decay for the new ded1 mutants, the 80S peak does not seem to increase proportionally especially in the 59-65/83-89 mutant. Based on the "mRNP" peak which should be a useful internal standard for the numbers of cells lysed, this mutant seems to have lost most of its ribosome content.
We appreciate the point, but don’t think that the proportion of total A260 present in the free mRNP peak can be assumed to be constant between WT and ded1 mutants in which the proportion of mRNA in mRNPs might well increase as the result of reduced polysome assembly.
Lastly, I'm surprised that the ded1-ts mutant on its own seems to have virtually no effect on translation even at the restrictive temperature of 36C which the legend to Figure 8 indicates was used here (cf. Figure 8A and Figure 8—figure supplement 2).
It cannot be said from the data in Figure 8A that the ded1-ts mutation has no impact on polysome assembly because the WT DED1 profile isn’t shown here. However, we had analyzed isogenic DED1+ cells in parallel and found, as expected, a significantly greater P/M ratio (3.90 +/- 0.11) compared to that shown in the figure for ded1-ts (2.39 +/- 0.10). This information has been added to the Figure 8A legend.
Reviewer #1 (Significance):
The work adds significant conceptual detail to our understanding of the role of Ded1 in translation initiation. On the path to understanding the mechanism of translation in any detail, this is essential work. Thanks to the thorough and methodologically broad approach used, the work strongly enhances our understanding of a central biological process, and since the interaction sites are highly conserved throughout eukaryotes, the work done here in yeast informs our understanding of general eukaryotic biology. Like any good study that forays into new territory, the work raises as many questions as it answers – one immediate one being questions around the order of events during complex formation in vivo as well as regulation of events during complex assembly. With alterations to the discussion based on my points above, I think this side would be presented more clearly. There is a strong history of fundamental studies into translation factors influencing and informing important fields including cancer (e.g. PMID 28653885) and other diseases (30038383, 30290184) and understanding fundamental translation factor biology is also becoming important for manipulating translation in bioprocessing and synthetic biology (27760840, 30615942). Thus, I have no doubt that the present study will be of interest to a wide readership.
As noted above, we altered the discussion based on several of the reviewer’s points.
Reviewer #2 (Evidence, reproducibility and clarity):
In this manuscript entitled "Distinct interactions of eIF4A and eIF4E with RNA helicase Ded1 stimulate translation in vivo", Gulay et al. identify separate amino acid clusters within the NTD of Ded1 required for interaction with eIF4E and eIF4A. They demonstrate that disruption of these clusters impairs cell growth, steady-state polysome levels and preferentially affects translation of an mRNA reporter with 5' UTR structure versus one with no/less structure. Disrupting Ded1 NTD interactions with eIF4E or eIF4E affected kinetics of 48S assembly on a synthetic mRNA with cap-proximal structure.
– If possible, can the authors provide us with a sense of the type of affinities that Ded1 has for eIF4E and eIF4A?
Based on K1/2 values determined by Gao et al. from kinetic analysis of unwinding of a model substrate, the affinity of Ded1 for eIF4A was estimated to be in the range of 45-800 nM, depending on whether Ded1 or eIF4A are present alone (800 nM) or eIF4A is complexed with RNA (45 nM) (Gao et al., 2016). Unfortunately, we have no estimate for the affinity of Ded1 for eIF4E.
– Figure 3D – there appears to be two bands for Ded1. Can the authors comment on these?
Unfortunately, we cannot comment definitively on this point.
It looks like in lane 8, there is reduced expression of D2-90 compared to the mutants in lanes 6 and 7. Perhaps quantification from several gels can be provided under the panel.
We added to Figure 3D the requested quantification of the Ded1/Hcr1 ratios determined from multiple replicates, and indicated in the legend to Figure 3D that the particular replicate shown here was atypical in suggesting a reduced level of the ded1-ts-Δ2-90 product vs. the parental ded1-ts product.
– Figure 6. How would the 4E binding mutants behave in this assay?
We had examined this previously and found no effect of eIF4A overexpression on the growth defect of the ded1-ts/59-65/83-89 allele, which is specifically defective for binding eIF4E. We have added this control observation in a new Supplementary figure to Figure 6 (Figure 6—figure supplement 1) and mentioned it in the text, which supports our interpretation of results in Figure 6B that eIF4A suppresses the growth defect of ded1 alleles that are partially defective for binding eIF4A by restoring Ded1-eIF4A association through mass action.
– The sentence "Hence it is conceivable that W88 and R27 mediate conserved interactions between Ded1 and its Ddx3 homologs in animals with eIF4E and eIF4A, respectively." is speculative. Please remove or rephrase to focus only on what is in the paper – the yeast data.
We have removed the sentence.
– Figure 8. Why was the Cap-proximal SL reporter used in D, rather than the cap-distal SL which showed a greater effect in panel C? Do the authors have data for the cap-distal SL.
In panel C, both reporters showed a marked reduction in expression for the two mutants impaired for binding eIF4A or eIF4E analyzed in panel D. Unfortunately, we don’t have data for the cap-distal SL reporter for the experiment in panel D, which is very labor-intensive.
– Figure 9. The nomenclature used for the mutants is different than what is used in the rest of the figures. Also, the numbers don't align properly with the columns in Panels A and B.
These small errors in the figure have been fixed.
– Figure 9 A, B. Can the authors provide the raw data for the results leading to the data in Panels A and B? Perhaps as a supplemental Figure.
This source data has been provided as a supplementary excel file.
Reviewer #3 (Evidence, reproducibility and clarity):
This manuscript by Gulay, et al. focuses on the function of Ded1, a DEAD-box RNA helicase, in translation initiation, specifically its interaction with the eIF4F translation complex. The authors identify small mutations in Ded1 that affect its interactions with eIF4A and eIF4E, and they utilize these mutants to examine the importance of the interactions for cell growth and translation in budding yeast using previously established in vivo and in vitro techniques. For the most part, the data and conclusions of the manuscript are solid; however, there are a few points at which further control experiments would be helpful and/or opportunities were missed to increase confidence in the results. There are also a few issues with interpretation/discussion that should be addressed.
1) In Figure 2, have the authors considered whether there might be competition for 4A and 4E binding to Ded1? This would not be consistent with their overall model, but it would explain the effects on 4A binding in the 51-57 mutant vs. 51-57/59-65 mutant. A competition binding experiment could reasonably be done with recombinant proteins in hand.
Such competition is not possible in this experiment as only GST-eIF4A or GST-eIF4E are present in the binding reactions.
2) In Figure 2—figure supplement 4, the single point mutants should be tested for effects on binding of both 4A and 4E as controls. This is especially relevant for the mutants in the 51-65 region that appear to have cross-antagonistic effects (point 1).
We have determined that R27A, which impairs binding to GST-eIF4A, does not affect binding to GST-eIF4E, as expected from the fact that the 21-27 substitution
(encompassing R27A) specifically impairs interaction with GST-eIF4A (Figure 2B-C). We had also determined that R51A does not impair binding to GST-eIF4E and that R83A does not affect binding to GST-eIF4A, indicating that neither of these Ded1 substitutions affect either interaction. These additional results have been added to Figure 2—figure supplement 4. While we have not tested the Y65A and W88A substitutions for their effects on binding to GST-eIF4A, it seems highly unlikely that they would impair this interaction considering that the 59-65 and 83-89 clustered Ala substitutions, which encompass Y65A and W88A, respectively, did not did so (Figure 2B).
3) Along these same lines, the Y21A mutant should be tested for 4D binding and possibly other defects (4G, enzymatic defects) since it has no 4A binding defect but significant in vivo phenotypes.
As already shown in Figure 2C, the 21-27 clustered Ala substitution, which encompasses Y21A, did not affect binding to GST-eIF4E, making it highly unlikely that Y21A would do so. We feel that understanding the molecular basis of the growth defect conferred by the Y65A substitution is outside the scope of this report.
4) The rationalization for the focus from Figure 3 on in using ded1-ts as a sensitized background is not very well-described. The mutants by themselves seem to have phenotypes (e.g. Figure 3C), why not use these without the possibly confounding effects of another mutation?
When we began the study, we weren’t sure if mutations specifically impairing either eIF4E or eIF4A would have a marked phenotype on their own, noting that deletion of the Ded1 CTD that eliminates the eIF4G binding site has no effect on cell growth in otherwise WT cells. Hence, we chose the standard genetic practice of using a sensitive background and evaluating synthetic phenotypes in combination with ded1-ts.
Along these same lines, the polysome profile of the ded1-ts control strain in Figure 8A is surprisingly normal (higher P/M than the DED1 strain in Figure 8—figure supplement 3) given that this strain was previously shown to have a substantial defect under less restrictive conditions (Sen et al., 2015).
As noted above for reviewer 2, we had analyzed isogenic DED1+ cells in parallel and found, as expected, a significantly greater P/M ratio (3.90 +/- 0.11) compared to that shown in the figure for ded1-ts (2.39 +/- 0.10). This information has been added to the Figure 8A legend.
5) The suppression experiments in Figures 6 and 7 are good genetic evidence. However, the authors' interpretation of the 21-27/51-57 double mutant does not seem to fit the data, since the interpretation relies on a complete ablation of 4A binding, while this mutant still appears to interact at a reduced level in vitro and in vivo.
We disagree that it can be concluded that the Ded1 21-27/51-57 double mutant retains residual binding to eIF4A, as the difference in binding to GST-eIF4A between this variant and complete deletion of the Ded1 NTD (ΔN) in Figure 2B is not statistically significant. In addition, the residual CoIP of eIF4A with the myc-tagged Ded1 harboring 21-27/51-57 could easily be mediated by eIF4G, whose coimmunoprecipitation is unaffected by these NTD substitutions.
Further, an additional control needed in Figure 6 is to express hcTIF1 in the 4E binding mutant (59-65/83-89) – if the authors are correct, it should not rescue growth. Also, have the authors attempted hcDED1 in a TIF1/TIF2 mutant? That would complement the other suppression experiments nicely. Finally, do the suppressions also rescue polysome and/or scanning defects as in Figure 8?
As mentioned above for reviewer 2, the predicted result was obtained as hcTIF1 does not suppress the growth defect of the 59-65/83-89 double mutation, and has been included in a new supplementary figure (Figure 6—figure supplement 1). We were unsure of the reviewer’s objective in asking us to test for suppression of a TIF1/TIF2 mutant by hcDED1, and unclear about what mutant should be examined. A new supplementary figure (Figure 8—figure supplement 5) and explanatory text has been added providing evidence that hcTIF1 mitigates the reduction in LUC reporter expression conferred by the ts/21 mutation (that allows residual eIF4A/Ded1 interaction) but not by the ts/21,51 mutation (that abolishes eIF4A interaction), nor by the ts/59,83 mutation that impairs eIF4E interaction (included as a negative control). Rescue by hcCDC33 was not attempted because eIF4E overexpression confers a slow-growth phenotype, which is why we reverted to overexpression of Ded1 in the cdc33-1 mutant in the genetic analysis of Figure 7.
6) The manuscript relies heavily on genetic arguments, but some caution is warranted, given that these arguments are often somewhat indirect. This is especially true given that no attempt is described at making mutations in 4A and 4E that do not interact with Ded1. I do not think constructing such mutants is required, but they should temper their conclusions and offer caveats throughout, especially when discussing the model in Figure 9C.
A statement has been added to the Discussion that, while it is impossible to rule out additional effects of the ded1 mutations beyond impairing Ded1 interaction with eIF4A or eIF4E, the genetic suppression experiments in Figures 6-7 provide strong evidence in favor of this interpretation.
7) In regard to the model, the authors claim that the 4A interaction may be "more important" than the 4E one, largely based on the in vitro translation assays in Figure 9. However, only the single (59-65) 4E-binding mutant was used in these assays compared to the double (21-27/51-57) 4A-binding mutant. Either the 51-57/83-89 double mutant should be tested, or the authors need to modify their claim about the relative importance of binding to the two factors.
We agree and have modified our claim accordingly in the Discussion.
1) The focus on how the 4A/4E mutants "exacerbate" defects caused by deletion of the CTD is a fairly weak point. The effects seem largely additive rather than necessarily illustrating a major aspect of the interaction with eIF4F. I would recommend moving Figure 4, for instance, to the supplement and somewhat reducing the prominence of commentary about the CTD in the manuscript. Additionally, it is not completely accurate that no studies have shown an in vivo effect of the Ded1-CTD and/or the Ded1-eIF4G interaction – Hilliker et al. showed some in vivo effects of the CTD deletion, Senissar et al. showed genetic interactions on growth with ded1 mutants and eIF4G, and Aryanpur et al., 2019, recently showed a significant in vivo effect of the CTD, linked to eIF4G interaction, in certain conditions.
We prefer to leave Figure 4 in its current position because we consider it significant that the deletion of the Ded1 CTD confers a growth defect only in the presence of the Ded1 NTD mutations that impair eIF4E or eIF4A binding, ie. we observe synthetic growth phenotypes between these NTD and ΔC mutations. This provides important evidence for additive effects of separate Ded1 interactions with eIF4A, eIF4E and eIF4G in assembly of an eIF4F·Ded1 complex that enhances Ded1 stimulation of translation. However, we have revised the Discussion to better explain the significance of this synthetic genetic interaction.
Re-examining the literature cited by the reviewer did not reveal any published findings that contradict our conclusion that the in vivo importance of the Ded1 CTD in stimulating translation at native levels of Ded1 expression has been unclear. Hilliker et al., 2011, observed a slight exacerbation of the Cs- phenotype of a double NTD mutation in combination with a deletion that spans the boundary between the core helicase and CTE of Ded1; and they found that a deletion in the CTD impairs Ded1 stimulation of translation in vitro, but it had no effect on cell growth even at low temperature where defects in Ded1 function are most readily observed. Senissar et al., 2014, examined no mutations in the Ded1 CTD. Aryanpur et al., 2019, recently uncovered an interesting role for the Ded1-CTD in TORC1-mediated down-regulation of translation initiation (rather than stimulation) during nutrient starvation. We have revised the Discussion to more thoroughly discuss our findings on the CTD in relation to these published findings.
2) The strain background used in the pull-downs in Figure 5 is described differently in the text compared to the figure legend and Table 2. First, tagged TIF4631 appears to be expressed from a plasmid, not from the eIF4G2 promoter. Second, was wild-type Ded1 present in these cells? If so, its presence in the pull-downs could be confounding in interpreting the results.
The strain descriptions are consistent throughout, but we have added explanatory information in the Results and Table indicating that the strain contains deletions of TIF4631 and TIF4632 and contains TIF4631-HA on a plasmid under the control of the TIF4632 promoter and transcription terminator, as described previously by Tarun and Sachs. We have also added text indicating that the presence of WT DED1 in the strain could be intensifying the effects of the mutations in the myc-tagged ded1 alleles on association with eIF4F components by competition for binding the latter.
3) In a number of the Western blots, the protein levels in the exposures shown are fairly saturated and do not appear to be in a linear range (e.g. Figure 6C). It is difficult to be sure the expression levels are actually similar if this is the case.
As noted above for reviewer 2, we have added quantification of Ded1 protein levels from multiple replicates to Figure 3D. For Figure 4B, there is no question that the Ded1 variants containing the point mutations are expressed as well or better than the parental WT or ΔC proteins, establishing the key objective of the Western analysis. For Figure 6C, the main purpose of the analysis was to confirm that eIF4A is comparably overexpressed in the key ts/21-27/51-57 mutant (lane 12) versus the other mutants (lanes 2, 4, 6, 8, 10), which we feel was achieved, noting that the eIF4A signals are invariably greater in the hcTIF1 vs. vector transformants.
4) In Figure 8C, the ded1-ts presumably already has defects compared to wild-type cells, especially in the stem-loop reporters. The authors should probably document these defects somewhere, even if they also show the relative differences as in Figure 8C. Along similar lines, in Figure 8—figure supplement 1, why are the ded1-ts values not all set to 1.0 like in Figure 8C? The legend indicates they should be the same as Figure 8C.
The defects in reporter expression conferred by ded1-ts are indicated in Figure 8—figure supplement 1, which has been cited explicitly in the Results; and the legend to Figure 8—figure supplement 1 has been modified to indicate that the results for the two SL reporters in the parental ded1-ts strain were not normalized to 1.0 in the manner conducted in Figure 8C.
5) Also regarding Figure 8C, the authors do not offer any interpretation of why the cap-proximal and cap-distal stem-loops are differentially affected by the different mutants. Why might this be?
As noted above for reviewer 1, we will add text to the Discussion regarding this point.
6) In Figure 8D, there does not appear to be any statistical analysis as to whether the observed changes are significant.
We have added a new supplementary figure (Figure 8—figure supplement 4) with evidence indicating statistically significant reductions in the proportions of the FLUC SL reporter found in heavy polysomes for both ded1 alleles harboring substitutions in the NTD vs. the parental ded1-ts allele.
Reviewer #3 (Significance):
This work advances our understanding of the mechanism of translation initiation, specifically the interactions of an RNA helicase, Ded1, that is known to be important in initiation, although its function has not been fully described. This study builds on previous work by this group and others (e.g. Hilliker et al., 2011; Senissar et al., 2014; Sen et al., 2015; Gao et al., 2016; Gupta et al., 2018) to better define the relationship of Ded1 and the eIF4F complex. As such, this work will be of significance to those in the translation field, particularly those studying initiation factors and/or RNA helicases. I expect that the identification of Ded1 binding determinants for eIF4A and eIF4E will be of marked interest for researchers studying these factors specifically. On a broad level, however, the research presented does not propose especially novel hypotheses or mechanisms and uses well-established techniques, so it is not likely to be appropriate for a high impact journal. This work is more of a "fill in the details" study, but it is solid work and should be published, pending the ability to address reviewer comments.
We respectfully disagree that this work merely “fills in details” as there was previously no compelling evidence that the individual interactions of eIF4A or eIF4E with Ded1 are important in vivo, nor that they are even more crucial when the Ded1CTD interaction with eIF4G is compromised. As such, the results provide the first strong evidence that robust Ded1 function in living cells is dependent on its association with the eIF4F complex, including separate contacts with each of its three subunits. Accomplishing this required a combination of genetics and biochemistry to map the locations of the distinct binding sites for eIF4A and eIF4E in the Ded1 NTD to the amino acid level, establish their importance for Ded1’s ability to enhance bulk and mRNA-specific translation in vivo and to stimulate 48S PIC assembly in a fully purified system; and also to demonstrate by suppressor analysis that the translation defects in vivo indeed arise from impaired association with eIF4A or eIF4E.https://doi.org/10.7554/eLife.58243.sa2
Article and author information
National Institutes of Health (Intramural Research Program)
- Suna Gulay
- Neha Gupta
- Jon R Lorsch
- Alan G Hinnebusch
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
We thank Roy Parker, Angie Hilliker, Alan Sachs, Patrick Linder, and Michael Altmann for gifts of yeast strains or plasmids, Patrick Linder, JEG McCarthy, and Tien-Hsien Chang for gifts of antibodies, and Neelam Sen for spike-in RNAs. We thank Neelam Sen, Fan Zhang, Swati Gaikwad, other members of our laboratories, Nick Guydosh, and Tom Dever for helpful comments and suggestions. This work was supported in part by the Intramural Research Program of the National Institutes of Health.
- James L Manley, Columbia University, United States
- Nahum Sonenberg, McGill University, Canada
- Received: April 24, 2020
- Accepted: May 28, 2020
- Accepted Manuscript published: May 29, 2020 (version 1)
- Version of Record published: July 8, 2020 (version 2)
This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
- Page views
Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
- Cell Biology
- Chromosomes and Gene Expression
The shape and size of the human cell nucleus is highly variable amongst cell types and tissues. Changes in nuclear morphology are associated with disease, including cancer, as well as with premature and normal aging. Despite the very fundamental nature of nuclear morphology, the cellular factors that determine nuclear shape and size are not well understood. To identify regulators of nuclear architecture in a systematic and unbiased fashion, we performed a high-throughput imaging-based siRNA screen targeting 867 nuclear proteins including chromatin-associated proteins, epigenetic regulators, and nuclear envelope components. Using multiple morphometric parameters and eliminating cell cycle effectors, we identified a set of novel determinants of nuclear size and shape. Interestingly, most identified factors altered nuclear morphology without affecting the levels of lamin proteins, which are known prominent regulators of nuclear shape. In contrast, a major group of nuclear shape regulators were modifiers of repressive heterochromatin. Biochemical and molecular analysis uncovered a direct physical interaction of histone H3 with lamin A mediated via combinatorial histone modifications. Furthermore, disease-causing lamin A mutations that result in disruption of nuclear shape inhibited lamin A-histone H3 interactions. Finally, oncogenic histone H3.3 mutants defective for H3K27 methylation resulted in nuclear morphology abnormalities. Altogether, our results represent a systematic exploration of cellular factors involved in determining nuclear morphology and they identify the interaction of lamin A with histone H3 as an important contributor to nuclear morphology in human cells.
- Biochemistry and Chemical Biology
- Chromosomes and Gene Expression
Cells have evolved the DNA damage response (DDR) pathways in response to DNA replication stress or DNA damage. In the ATR-Chk1 DDR pathway, it has been proposed that ATR is recruited to RPA-coated single-stranded DNA (ssDNA) by direct ATRIP-RPA interaction. However, it remains elusive how ATRIP is recruited to ssDNA in an RPA-independent manner. Here, we provide evidence that APE1 directly associates ssDNA to recruit ATRIP onto ssDNA in an RPA-independent fashion. The N-terminal motif within APE1 is required and sufficient for the APE1-ATRIP interaction in vitro and the distinct APE1-ATRIP interaction is required for ATRIP recruitment to ssDNA and the ATR-Chk1 DDR pathway activation in Xenopus egg extracts. In addition, APE1 directly associates with RPA70 and RPA32 via two distinct motifs. Taken together, our evidence suggests that APE1 recruits ATRIP onto ssDNA in an RPA-dependent and -independent manner in the ATR DDR pathway.